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The N-acetyl amino acids, such as N-acetyl-L-methionine (NALM), ƐN-acetyl-L-
lysine, and Nα, ε-acetyl-L-Lysine are amino acid (AA) derivatives and developmental 
forms of rumen-protected (RP) AAs for dairy cows (CJ CheilJedang). The AA derivates 
are produced via N-acetylation of the L-Met α-amino, L-Lys α-amino or ε-amino group, 
respectively. Three independent studies were conducted to investigate the use of Met and 
Lys acetylation derivatives as sources of RPAAs for lactating dairy cows. The initial 
study investigated production responses and ruminal fermentation characteristics of 
lactating dairy cows when supplemented with NALM as a source of RPMet in 
metabolizable protein (MP) -deficient or MP-adequate diets. Supplementation of NALM 
increased milk fat concentration and yield and 3.5% fat-corrected milk (FCM) yield and 
tended to increase energy-corrected milk (ECM) yield regardless of MP difference. 
iv 
 
Dietary treatments had similar effects on ruminal fermentation characteristics and 
microbial protein yield. Results from the first study suggest that NALM exerted minor 
influence on ruminal metabolism, but increased milk fat concentration, resulting in 
increases in milk fat yield and feed efficiency. 
The subsequent study investigated lactational performance of dairy cows when 
supplemented with N-acetyl-L-Lysine (NALL), N, -acetyl-L-Lysine (diNALL), or 
AjiPro-L (AP) as a source of RPLys to a control diet. Feeding the diNALL and AP diets 
decreased dry matter intake. Stage of lactation may have altered DMI in cows fed the 
diNALL and AP diets because energy requirements decrease during mid-lactation and 
control of feed intake is regulated by hepatic oxidation. Milk yield was not altered by 
RPLys supplementation. Findings from the study indicate that supplementing N, -
acetyl-L-Lysine in mid to late lactation dairy cows decreases DMI and maintained milk 
yield leading to improved milk production efficiency (milk yield/DMI).  
The final study evaluated the bioavailability (BA) and lactational performance of 
lactating dairy cows supplemented with NALM at two different supplementation rates. 
Overall, production parameters were not influenced by NALM supplementation. 
Bioavailability, as assessed by plasma appearance of Met was higher for the 30g NALM 
dose compared with 60g NALM and control, suggesting that optimal supplementation 
rate for NALM is 30 g/cow/d. Residue of NALM was not detected in plasma, milk, liver 
or muscle samples. Overall, findings suggest that NALM is deacetylated before reaching 
central circulation, increases plasma Met concentrations, therefore supplying lactating 
dairy cows with a BA source of RPMet. 
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Investigation of Methionine and Lysine Derivatives as a Source of Rumen-Protected 
Amino Acids for Lactating Dairy Cows 
 
Mark Avila Fagundes 
 
Cows have a protein requirement for growth, maintenance, and lactation. In order to 
meet those protein requirements, dairy farmers can supplement or feed cattle with 
specific amino acids, the building blocks that make-up protein. However, in order for the 
amino acid product to be effective it must avoid degradation in the rumen and be 
delivered in the small intestine for absorption. Lysine and methionine have traditionally 
been recognized as the most limiting amino acids for lactating dairy cows. Therefore, 
nutrition companies have focused on finding ways to encapsulate or protect lysine and 
methionine from rumen microbes. The N-acetyl-L-methionine and N-acetyl-L-lysine are 
amino acid derivatives and developmental forms of amino acids for dairy cows. Three 
separate nutrition studies were conducted to investigate the use of lysine and methionine 
acetylated derivatives as sources of amino acids for lactating dairy cows. The initial study 
investigated milk production responses of lactating dairy cows when supplemented with 
N-acetyl-L-methionine. Supplementation of N-acetyl-L-methionine increased milk fat 
vi 
 
concentration and yield and 3.5% fat-corrected milk yield. Results from the first study 
suggest that N-acetyl-L-methionine did not impact rumen metabolism, but increased milk 
fat concentration by providing methyl donors to the mammary gland, resulting in 
increases in milk fat yield. The second study investigated lactational performance of 
dairy cows when supplemented with N-acetyl-L-lysine, N, -acetyl-L-lysine, or 
AjiPro-L as a source of rumen-protected lysine. Feeding the N, -acetyl-L-lysine and 
AjiPro-L diets decreased dry matter intake. Milk yield was not altered by rumen-
protected lysine supplementation. Findings from the study suggest that supplementing 
N, -acetyl-L-lysine to dairy cows decreases dry matter intake, but maintained milk 
yield leading to improved milk production efficiency. The final study evaluated the 
bioavailability and lactational performance of dairy cows supplemented with N-acetyl-L-
methionine. Overall, milk production parameters were not affected by N-acetyl-L-
methionine supplementation. Bioavailability was higher for diets with N-acetyl-L-
methionine compared with the control diet. Residue of N-acetyl-L-methionine was not 
detected in plasma, milk, liver, or muscle samples. Overall, findings suggest that N-
acetyl-L-methionine is deacetylated and absorbed as methionine into the bloodstream of 
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Lysine (Lys) and methionine (Met) have traditionally been recognized as the most limiting 
amino acids (AA) for lactating dairy cows fed corn-based diets (Schwab et al., 1992; NRC, 
2001). Protein nutrition of dairy cows in recent years has shifted from the use of dietary crude 
protein (CP) towards meeting the ammonia and AA needs for ruminal fermentation in order to 
maximize microbial protein (MCP) synthesis (Schwab and Broderick, 2017). Another nutritional 
shift seen recently is the balancing of individual AA in metabolizable protein (MP) as a method 
to deliver bioavailable AAs to the small intestine. However, in order for an AA product to reach 
the small intestine for absorption, it must be protected from rumen microbial degradation.  
Protection of free AAs from ruminal degradation dates to the 1960s (Schwab and Broderick, 
2017) and numerous rumen-protected AA (RPAA) products, have been developed using a 
variety of technologies. In terms of Met, encapsulation of a Met molecule with coating materials, 
such as carbohydrates or polymer allows RPAA products to avoid ruminal degradation (Schwab 
and Ordway, 2003). Altering the structural configuration of AAs to avoid microbial degradation 
is another method to escape rumen degradation. Methionine analogues utilize a hydroxyl group 
to protect them from ruminal degradation and are converted to useable Met by enzymatic 
reactions (Schwab and Ordway, 2003). Rumen-protected Lys (RPLys) products are often coated 
by a series of lipid or fatty acid calcium-based salts (Ji et al., 2016). Encapsulated rumen-
protected Met (RPMet) and Met analogues can impact milk yield, but their effects tend to be 
more prominent in altering milk fat and protein composition (Patton, 2010; Zanton et al., 2014). 
Encapsulated RPLys supplementation has minimal impact on production parameters, unless 




supplemental RPMet and RPLys in the literature are inconsistent and require further research. 
Inconsistent findings may be related to AA protection methods, varying supplementation rates, 
or metabolizable protein concentrations in the diets. 
The N-acetyl-L-Met (NALM), ƐN-acetyl-L-Lys (εNALL), and Nα, ε-acetyl-L-Lys 
(diNALL) are AA derivatives and developmental forms of RPAAs for lactating dairy cows. 
Based on prior research, it is thought that the acetyl group acts as a barrier to block the 
hydrolysis of the AA N-terminal (Wallace, 1992). However, to our knowledge there is limited 
production and bioavailability data available on the supplementation of acetylated AA 
derivatives to lactating dairy cows (Amaro et al., 2019; Digenis et al., 1974; Liang et al., 2019; 
Windschitl and Stern 1988). 
Therefore, a series of lactation studies were performed to investigate the use of acetylated 
Met and Lys derivatives as a source of RPAAs for lactating dairy cows. Three independent 
studies were conducted, and it was hypothesized that; for study 1) increased Met from NALM 
would increase milk protein synthesis and milk yield, but the degree of the response would be 
dependent upon the MP supply in the diets; for study 2) increased post-ruminal Lys from 
developmental NALL products would increase milk protein synthesis and milk yield compared 
with the control diet and for study 3) Met from abomasal infusion of NALM would increase 
plasma Met concentration, and the bioavailability of NALM would be greater for each dose 
compared with the control leading to a dose response, while lactational performance would be 







REVIEW OF LITERATURE 
 
Methionine and Lys are recognized as the 2 most limiting AAs for milk protein synthesis and 
milk production in lactating dairy cows. Individual or combined supplementation of RPAAs in 
ruminant diets is not a new concept, but in recent years has become more popular due to the 
beneficial effects of RPLys and RPMet on lactational performance (Robinson, 2010; Zanton et 
al., 2014). Supplementation of RPMet can improve milk fat (Overton et al., 1998; Samuelson et 
al., 2001) and protein yield (Rulquin and Delaby, 1997; Patton, 2010), while RPLys tends to 
exert its beneficial effects on milk protein yields (Robinson, 2010). As the dairy industry 
continues to find solutions to reduce environmental impact, nitrogen (N) efficiency can be 
improved by reducing protein concentrations in ruminant diets with strategic supplementation of 
RPAAs. For these reasons, feeding RPAAs has gained popularity in the dairy industry. This 
literature review will cover the common RPLys and RPMet products available for use in 
ruminants, as well as their effects on feed intake, milk and milk component production, 
immunity, metabolism, intestinal absorption of AA, mammary gland AA metabolism, and 
bioavailability. Main focus will be placed on encapsulated RPAAs, Met analogues, and AA 









In recent decades, significant progress has been made in understanding the AA nutrition of 
dairy cows. Ruminal protein metabolism and the discovery of bacterial protein synthesis have 
been comprehensively researched (Wegner et al., 1940). Dairy cows can utilize nonprotein N 
(e.g., urea) and free ammonia from ruminal AA degradation for MCP synthesis. Ruminal MCP is 
the major form of MP supplied to (50-80%) and absorbed from the small intestine of dairy cows 
(Storm and Ørskov, 1983). Microbial protein is considered a high-quality protein for dairy cows 
because of its high digestibility and favorable AA composition (Schwab and Broderick, 2017). 
However, MCP synthesis requires large amounts of energy with the efficiency of energetic 
transformations for protein synthesis from AA being less than 75% (Wu, 2013). Therefore, much 
attention has been placed on the development of RPAAs to escape rumen degradation and supply 
high-quality, systemically available AAs in ruminant diets.  
Historically, AA dietary formulations for dairy cows have been based on the single-limiting 
AA theory (Mitchell and Block, 1946), which was adapted from the law of the minimum 
proposed by von Lieberg (1863; Liu et al., 2017). Recently, the single-limiting AA theory has 
been refuted (Appuhamy et al., 2012; Liu et al., 2017). A revised conceptual framework with the 
NRC (2001) model that represents the individual and additive effects of all 10 essential AA 
(EAA) is believed to improve model accuracy compared with the single-limiting AA model in 
ruminants (Liu et al., 2017). Thus, when a ration is formulated based on the single-limiting AA 
theory, the additive effects of EAA for lactational AA requirements are ignored, and production 
responses may be altered. Balancing rations for EAA requirements of dairy cows and for 
multiple-limiting AAs may help to reduce overfeeding of protein, improve post-ruminal AA 





Of the 20 primary AAs that occur in proteins, 10 are classified as being ‘‘essential’’ (or 
indispensable) (NRC, 2001). Essential AAs cannot be synthesized by animal tissues or if they 
can (arginine and histidine), not at rates sufficient to meet requirements at early stages of growth 
or for high levels of production (NRC, 2001). Lysine and Met have been identified as the 2 most-
limiting EAAs for lactating dairy cows, with current evidence suggesting that histidine (His) 
may be limiting in grass silage-based diets (Vanhatalo et al., 1999; Giallongo et al., 2016). Since 
His concentrations are lower in ruminal MCP compared with milk protein and common 
feedstuffs (NRC, 2001), His may be a limiting EAA for lactating cows fed MP-deficient diets. 
This is of most significance when MCP provides or encompasses most of the MP supplied to 
ruminants (Patton et al., 2014; Giallongo et al., 2016).   
Branched chain amino acids (BCAA) are used by the mammary gland for cellular, milk 
protein synthesis and comprise 50% of the EAA in milk proteins (Mackle et al., 1999). It has 
been suggested that BCAAs may be as limiting as Met and Lys in high producing dairy cows 
(Appuhamy et al., 2011), because of obligate use of BCAAs (isoleucine (Ile), leucine (Leu), and 
valine (Val)) by intestinal tissue as energy sources. A meta-analysis was performed (Lean et al., 
2018) to predict the effects of metabolizable AAs on dairy cattle performance. The researchers 
found a positive association of Cornell Net Carbohydrate and Protein System estimated 
metabolizable Leu with milk protein and milk yield responses, suggesting that Leu should be 
given greater consideration as a potential co-limiting AA (Lean et al., 2018). However, the 
effects of BCAA supplementation on dairy cow production is varying and further evidence is 
needed to determine if BCAAs should be considered as limiting AAs in dairy diets for 




Methionine and Lys are the most researched AAs in regards to dairy cattle nutrition. They are 
considered the most limiting EAA for the synthesis of milk and milk protein in the high-
producing dairy cow (Schwab et al., 1992; Rulquin et al., 1993). Methionine is one of 4 sulfur-
containing AAs and along with cysteine is proteogenic (Brosnan and Bronson, 2006). In 
ruminants, Met is not only used for protein synthesis, but serves multiple biological roles (Figure 
1). Milk protein synthesis by lactating dairy cattle can be altered if Met is in the shortest dietary 
supply of available dietary AAs requirements based on the single-limiting AA theory (Mitchell 
and Block, 1946). Methionine functions as a methyl donor and precursor to antioxidant and 
lipotropic compounds including carnitine, choline, creatine, cysteine, glutathione, 
metallothionine, taurine and S-adenosyl methionine (SAM) (Lehninger, 1977; Seymour, 2016; 
Figure 1).  
Previously, research has focused on the role of Met as a co-limiting AA for milk protein and 
fat synthesis, and maintaining metabolic balance (Polan et al., 1991; Seymour, 2016). Recently, 
the metabolic functions of Met such as its role in supporting liver function, oxidative balance, 
and immunity have been assessed (Osorio et al., 2013). Methionine deficiency in non-ruminants 
produces fatty liver disease, a reduction in cellular antioxidants, reduced methyl donors, and 
generalized hepatic inflammation and fibrosis (Schugar and Crawford, 2012). Unlike the 
variability of Met’s biological functions, the predominant biological function of Lys is protein 
synthesis (milk protein, growth, pregnancy, and maintenance) (NRC, 2001). It is evident that 
Met and Lys are essential for milk and milk component production and serve many biological 
roles. However, the chemical form of AA fed to dairy cattle can alter the absorption, utilization 





Structural Configuration and Biological Functions of Met and Lys 
 
Methionine and all protein AAs, except glycine, can have both D- and L-isomers. L-AAs are 
physiological isomers in organisms and account for greater than 99.98% of the total AAs in the 
body (Wu, 2013). In dairy cows, the D-isomer is not bioavailable (Lapierre et al., 2012). The D-
isomer must be converted to the L-isomer before it can be incorporated into mammalian proteins. 
Supplementation of the L-isomer of Met can be utilized directly for protein synthesis without 
conversion to any other isoforms. Since chemical synthesis of AAs results in a racemic mixture 
of the D- and L-enantiomers of Met, the bioavailability (BA) of the D- isomer of Met in dairy 
cows depends on the rate of transformation into the L-isomer (Lapierre et al., 2012).  
For ruminants, BA data of D-Met are limited and somewhat unclear. In small ruminants, 
lower utilization of D-Met than L-Met has been described (Doyle, 1981), while the utilization of 
D-Met and L-Met appear to be equally effective for supporting wool growth (Doyle, 1981; Reis 
et al., 1989). In growing steers, D- and L-Met produced similar increases in N retention 
(Campbell et al., 1996), although this tended to be lower with DL-Met infusion compared with 
an equimolar dose of L-Met (Titgemeyer and Merchen, 1990). In both bovine studies, plasma 
total Met concentrations (D plus L) were greater when either D- or DL-Met was provided 
compared with similar supplementation of the L-enantiomer (Lapierre et al., 2012). Lobley et al., 
(2001) found that feeding RPMet with the 2 enantiomers (D- and L-) to dairy cows results in 
accumulation of plasma D-Met, which could be an indication of poorer systemic utilization of D-
Met. From this research, it seems that both enantiomers increase D-Met plasma concentration, 




To date, the research by Lapierre et al., (2012) is the most thorough to determine the BA of 
D-Met in dairy cows. The researchers sought to quantify the conversion of D-Met to the L-
isomer, proportion of D-Met plasma removal, and L-Met conversion, and determine if the 
conversion of D- to L-Met occurs in the mammary gland of dairy cows (Lapierre et al., 2012). 
The findings from this study indicate that the D-enantiomer of Met, constituting half of the Met 
in rumen-protected products, is transformed to the L-enantiomer in dairy cows. The whole body 
rate of disappearance of D-Met is, however, much slower than that of L-Met, with the half-life of 
D-Met being 6 to 7 times longer than that of L-Met (Lapierre et al., 2012). The non-utilization of 
D-Met by the mammary gland and a lower hepatic extraction of D-Met compared with L-Met 
would contribute to the slower rate of disappearance (Lapierre et al., 2012). The longer half-life 
of D-Met could be useful as it offers the opportunity to delay the clearance of the absorbed Met 
or act as a reservoir for L-Met synthesis (Lapierre et al., 2012).  
The diversity of AAs is influenced by structural configuration (e.g., side chains), which 
determines a specific AAs chemical property, such as reactivity, solubility, stability, and taste 
(Wu, 2013). The R-group of Met contains a methyl group covalently bonded to a sulfur atom. 
Methionine is among the most hydrophobic of the AAs and its electrophilic qualities are 
attributed to the terminal methyl group and sulfur atom (Brosnan et al., 2007). This means that 
most of the Met residues in globular proteins are found in the interior hydrophobic core, in 
membrane-spanning protein domains, and Met is often found to interact with the lipid bilayer 
(Brosnan and Brosnan, 2006). Methionine must bind to initiator tRNA in order for the pre-
initiation complex to form during the beginning of protein synthesis in eukaryotes (N-formyl-
Met in bacteria) and it is believed that the hydrophobic nature of Met is essential for protein 




Lysine is a basic AA characterized by the presence of an amino group at the end of a 4-
carbon aliphatic side chain and bears a positive charge at physiological pH (Tomé and Bos, 
2007). This structure makes Lys a reactive component in different chemical reactions including 
carbonyl-amine interactions. As a consequence, a segment of Lys can be degraded, and another 
part can become unavailable in different food systems because of its involvement in different 
interactions with AA side chains or with other components including carbohydrates or lipids 
(Tomé and Bos, 2007). As a result, its ε-amino group side chain easily forms covalent bonds 
with other AAs and reducing sugars known as the Maillard reaction (Ordway and Aines, 2010). 
Even when Lys is incorporated into peptides or proteins, its ε-amino group remains reactive and 
can still form covalent bonds (Nursten, 2005). Although all AA, peptides, and proteins can 
participate in the Maillard reaction, Lys is the most common and prevalent AA that participates 
(Ordway and Aines, 2010). 
 




Protection of free AAs from ruminal degradation dates back to the 1960s when researchers 
began to understand the importance of balancing AA in order to meet dairy cows AA 
requirements (Schwab and Broderick, 2017). The first RPMet supplement was developed by 
Delmar Chemicals (LaSalle, QC, Canada). This product consisted of a core of 20% DL-Met, 
colloidal kaolin, and tristearin (Schwab and Broderick, 2017). The encapsulated DL-Met product 




component yields (Broderick et al., 1970). However, plasma Met concentrations were increased 
at the higher supplementation rates (Broderick et al., 1970). Abomasal infusion of the 
encapsulated DL-Met product to lactating cows increased both milk protein yield and 
concentration. Plasma AA concentrations were altered when casein plus the encapsulated DL-
Met were abomasally infused. These results suggest that the Delmar product was a successfully 
developed commercial RPMet product (Broderick et al., 1970); however, it was later found to 
have poor intestinal digestibility (Grass and Unangst, 1972). These findings highlighted the 
reality that developing encapsulated products with both high rumen protection and intestinal 
release was not an easy task. 
Since this initial RPMet research, many approaches have been investigated to increase 
ruminal protection of Met products. In the 1980s and 1990s, Met analogues and derivatives were 
screened to find alternatives to encapsulation. Methionine analogues and derivatives provide the 
precursors for enzymatic conversion to Met. However, the screening was unsuccessful, and 
attention was again focused on improving encapsulation technologies (Schwab and Broderick, 
2017). Today RPAA products are marketed as being either; physically encapsulated or protected 
AA, AA analogues, or AA derivatives. The most popular RPMet products currently fed to dairy 
cows are physically protected and Met analogues. A brief review will be given on the 2 popular 
physically protected RPMet products, and special attention will be given to Met analogues in this 
review as they are structurally and functionally similar to Met derivatives.  
Physical protection approaches have been utilized other than lipid coating to protect Met with 
a surface coated carbohydrate (Mepron M85®, Evonik Inc., Kennesaw, GA). The Mepron® 
pellets consist of an 85% DL-Met core and are coated with several thin layers of ethylcellulose 




degradation of the products occurs through physical action and abrasion. This results in minimal 
rumen degradation and slow release of DL-Met in the small intestine (Schwab and Ordway, 
2003). Smartamine® M (Adisseo Inc., Alpharetta, GA) is a lipid/pH-sensitive polymer coated 
product. The core contains 75% DL-Met and is covered with ethylcellulose, stearic acid, and a 
small droplet of 2-vinylpyridine-co-styrene. This copolymer arrangement allows the product to 
escape ruminal degradation and become solubilized at the low abomasal pH of 2, thus allowing 
free DL-Met to be released in the abomasum (Schwab and Ordway, 2003). 
The Met analogues currently used in the dairy industry are Met hydroxy analogue (MHA or 
HMTBa) (ALIMET®, Novus International Inc., St. Louis, MO), calcium bis MHA (MFP®, 
Novus International Inc.), the isopropyl ester of 2-hydroxy-4-methylthiobutanoic acid (HMBi) 
(MetaSmart® Liquid, Adisseo Inc.) and butanoic acid, 2-hydroxy-4-(methylthio)-1-methylethyl 
ester (MetaSmart® Dry, Adisseo Inc.). The ALIMET® is a liquid 2-hydroxy-4-
methylthiobutanoic acid (HMB) product with the substitution of the α-amino group of Met with 
a hydroxyl group. The manufacturers’ data sheet does not state a minimum L-Met or DL-Met 
hydroxy analogue percentage (Novus International Inc. 2015). The minimum Met activity as a 
percent of DM in beef and dairy is 100%. The minimum activity is 88% in all other species. The 
product has a chemical formula of C5H10O3S. The ALIMET
® is a light brown to brown liquid 
with a characteristic sulfur odor. The pH of the product is less than 1. Boiling point is observed 
at 121°C and the flash point using Pensky-Martens Closed Cup is greater than 116°C. The vapor 
pressure is 16 mm Hg at 25°C. The material density is heavier than water, but is completely 





The MFP® is the dry-pelleted HMB calcium with substitution of the α-amino group of Met 
with a hydroxyl group (Novus International Inc. 2015). The product has a minimum DL-Met 
hydroxy analogue calcium content of 95%. The minimum Met activity is 84%. The product has a 
chemical formula of C5H10O3S . ½  Ca. The MFP
® is a light tan to tan granular powder with a 
cherry odor/flavor and a pH of 11 at 5% solution. The MFP® has a solubility of 74 g/kg at 25°C, 
and the material density is 800-850 kg/m3 (loose). The MFP® is not oxidative and has dust 
explosion class ST1 (weak explosion). The shelf life is a minimum of 5 years when stored as 
directed (Novus International Inc. 2015). 
The MetaSmart® Liquid (Adisseo Inc. 2018) is a liquid HMBi (95%) product with the 
substitution of the α-amino group of Met with an isopropyl ester group. The product has a 
chemical formula of C8H16O3S. It has a colorless to brown liquid appearance and a pH of 3.6. It 
has a melting/freezing point of -35.2°/-30.4°C. The product degrades prior to boiling. The flash 
point using Pensky-Martens Closed Cup is 115°C. The vapor pressure (Pa) is 0.6% at 25°C. The 
specific gravity is 1.07 at 20°C and has a solubility in water of 25.1 g/L at 30°C (Adisseo Inc. 
2018). 
The MetaSmart® Dry is a dry HMB product with the substitution of the α-amino group of 
Met with an ester group (Adisseo Inc. 2018). The product has a chemical formula of C6H12O3S. 
It is free-flowing, cream to beige-colored powder, consisting of butanoic acid, 2-hydroxy-4-
(methylthio)-1-methylethyl ester (50-75% by weight) adsorbed onto a silicon dioxide carrier (25-
50% by weight). The product has a flash point of > 93°C. The specific gravity is 0.75 g/cm3 
(loose), 0.80 g/cm3 (packed), and the product is insoluble in water (Adisseo Inc. 2018). 
The first Met analogue extensively studied was MHA (DL-α-hydroxy-γ-mercaptobutyrate) or 




ruminal degradation than free Met and its production is less expensive than that of DL-Met 
protected supplements such as Smartamine M (Wilson et al., 2008). Estimated bypass rates of 
HMB range from 99 (Jones et al., 1988) to 6% (Noftsger et al., 2005). Supplementation of HMB 
has a moderate effect on increasing plasma Met concentrations in dairy cows (Koenig et al., 
1999; Koenig et al., 2002). In order for the body to utilize HMB as useable Met, HMB must be 
converted to L-Met in a two-step process. In the first step, HMB is enzymatically converted to 2-
keto-4-(methylthio) butanoic acid (KMB). In the second step, transamination of KMB yields 
useable body Met (L-Met) (Dibner and Knight, 1984). 
Several esters of HMB have been developed in an attempt to increase its rumen protection. 
Comparing microbial degradation of several HMB esters, HMBi was estimated to have 60% 
protection, but methyl, ethyl, butyl, and cyclohexyl esters were more readily hydrolyzed to HMB 
in the rumen (Robert et al., 2001). The ability of HMBi to avoid hydrolysis suggests that 
isopropyl esters present a steric hindrance of ruminal bacterial esterases. In order for HMBi to be 
converted to useable body Met, HMBi must be hydrolyzed to HMB and isopropanol. Then, 
HMB is converted to KMB and L-Met (Dibner and Knight, 1984).  
Methionine derivatives are the least studied form of RPMet. A Met derivative is a free Met 
molecule with a chemical blocking group added to the α-amino group or a Met molecule in 
which the acyl group has been modified (Schwab and Ordway, 2003). Methionine derivatives 
add a chemical tail to the α-amino group, while Met analogues change the structural 
configuration of the α-amino group. There are 2 enzymes capable of converting AA derivatives 
to their corresponding AAs, to be utilized as body AAs. The enzyme aminoacylase I is present in 
multiple mammalian organs (small intestine, liver, and kidney) (Giardina et al., 1997). The 




α-N-acylated AAs to yield acetate and the corresponding AAs (Met or Lys) (Gade and Brown, 
1981). 
Digenis et al. (1974) screened 31 nitrogenous compounds with possible Met activity. The 
compounds were screened in vitro with rumen microbes and compounds not supporting cellulose 
digestion were included in studies to confirm resistance to rumen microbial degradation. N-
acetyl-DL-Met (NAM) and DL-homocysteine thiolactone hydrochloride were the most stable 
toward microbial degradation (Digenis et al., 1974).  
Windschitl and Stern (1988) reported that Met flowing out of continuous cultures increased 
with NAM supplementation without a change in bacterial Met flow, which was attributed to 
greater escape (67%) of the NAM from bacterial degradation. Daabees et al., (1984) 
supplemented NALM to young pigs and revealed that plasma Met concentration increased, but 
no NALM was present in either portal or vena caval plasma at any sampling time, thus indicating 
NALM deacetylation to Met in the intestinal lumen or mucosal cells with release of free Met to 
the plasma. Additionally, Amos et al. (1974) abomasally infused sheep with NAM and found 
that plasma Met concentration increased 1 h post infusion compared with the control treatment. 
Based on the prior data, it seems that NAM can bypass the rumen and that both NAM and 
NALM can increase plasma Met concentrations. However, research for NALM has not reported 
the BA of NALM fed to lactating dairy cows. These in vitro and in vivo findings revealed the 
potential use of Met derivatives as a RPMet source to lactating dairy cows; however, it was not 







Extensive research has focused on RPMet products. However, there are limited publications 
on RPLys products. This is primarily due to difficulties with development and production of 
rumen stable and efficacious RPLys products. As previously discussed, the Lys side chain is 
highly reactive and can react with encapsulation materials, such as polymer. Encapsulated Lys 
has a lack of resistance to TMR mixing and ruminant mastication (Swanepoel et al., 2010). 
Product stability of RPLys in wet TMR has been overlooked in recent years. A study conducted 
by Ji et al. (2016) assessed whether mechanical mixing of TMR or TMR with low or high 
moisture content alters Lys release from 6 RPLys products. The authors concluded that 
mechanical feed mixing, dietary moisture content, and exposure of RPLys to other feed 
ingredients in the TMR over time may damage the protective coating and reduce efficacy of 
RPLys products (Ji et al., 2016). Although differences in Lys release among RPLys products 
were found, inferences about RPLys product BA is cautioned, as altered protection of Lys does 
not determine free Lys delivery to the plasma and systemic availability to the cow (Block and 
Jenkins, 1994; Ji et al., 2016). 
 Inconsistent post-ruminal polymer degradation and high production costs have also limited 
the development of RPLys products (Swanepoel et al., 2010). However, there has been success 
since the early 1990s in developing rumen stable AA matrixes and a number of RPLys products 
have become available for commercial use (Robinson, 2009b). Available commercial RPLys 
products use encapsulation, matrix technology, or a combination of both to protect a Lys core 
from ruminal degradation (Ji et al., 2016). These RPLys products are often coated by a series of 
lipid or fatty acid calcium-based salts (Ji et al., 2016). Wu and Papas (1997) found that RPLys 
coating protection efficacy in the rumen depends on coating composition, pellet surface 




Because the majority of RPLys products are lipid-coated, questions have arisen about the 
rumen environment (i.e., water content and acidity) and stability of lipid coated RPLys products. 
Acid can catalyze the hydrolysis of triglycerides to fatty acids and glycerol (Bender et al., 1961; 
Carey, 2003), and acid-catalyzed hydrolysis occurs in environments with high water 
concentrations, such as in the rumen (Bender et al., 1961; Carey, 2003). Thus, Reiners et al. 
(2018) sought to determine the effects of acidity and silage source on Lys retained by 2 RPLys 
products and to estimate ruminal degradation of Lys retained by RPLys after mechanical mixing 
with alfalfa or corn silage with different amounts of acidity (pH). The authors concluded that 
physical and chemical dietary characteristics can affect Lys provided to ruminants from RPLys 
products (Reiners et al., 2018). They state that Lys concentration was reduced from the two 
RPLys products when mixed in silage-based diets before cows consume the diet (Reiners et al., 
2018). Because chemical and physical dietary factors along with on-farm feeding practices 
(mixing times) can impact RPLys efficacy, additional research is needed to find ways to 
minimize Lys loss. The most popular RPLys products currently fed to dairy cows are physically 
protected. A brief review will be given on 2 popular physically protected lipid RPLys products. 
AjiPro-L® (Ajinomoto Co. Inc., Tokyo, Japan) is a small white oval bead composed of L-Lys 
monohydrochloride (50% minimum) core, vegetable oil (49%) and lecithin (1%). The 
hydrogenated vegetable oil matrix in AjiPro-L resists physical damage while its hydrophobic 
layer prevents the microbial breakdown of Lys (Reiners et al., 2018). USA Lysine® (Kemin 
Industries, Des Moines, IA) is a beige to light brown particle composed of a L-Lys 
monohydrochloride (65% minimum) core. It is manufactured by extrusion of L-Lys-HCl and 
lipid (vegetable oil) into small particles and subsequently the Lys lipid particles are coated with 




Lysine derivatives, like Met derivatives are the least studied form of RPLys. A Lys derivative 
is a free Lys molecule that has a chemical blocking group added to either the α-amino or ε-amino 
group. The focus of this dissertation is on AA derivatives, specifically NALM and NALL. For 
now, the review will focus on production responses of lactating dairy cows to encapsulated AA 
supplementation, Met analogue supplementation, and briefly cover NALM supplementation. To 
our knowledge, NALL supplementation to lactating dairy cows has not been described in the 
literature and therefore only encapsulated RPLys production responses will be discussed.  
 
Effects on Intake 
 
Dry matter intake (DMI) is the amount of feed an animal consumes that does not include 
moisture content. Dry matter intake is significant in nutrition, because it determines the amount 
of nutrients available to an animal for health, production, and other physiologic processes (NRC, 
2001). Actual or estimated DMI is important for the formulation of diets to prevent underfeeding 
or overfeeding of nutrients and to promote efficient nutrient use (NRC, 2001). A variety of 
factors can influence DMI including forage quality, TMR nutrient balance, feeding delivery, 
feeding method, TMR palatability, ration dry matter (DM), environmental conditions, housing 
facilities, and managerial practices.  
Amino acids, especially His have been shown to increase DMI in lactating dairy cows (Lee et 
al., 2012b; Giallongo et al., 2016). The exact mechanism of increased DMI is unknown, but it is 
speculated that His and other EAA regulate DMI via a direct effect in the anterior prepyriform 
cortex of the brain (Rudell et al., 2011). Methionine on the other hand if overfed can have a 




reported that DMI response was affected by supplemental Met source (Smartamine, Mepron, 
HMTBa, and DL-Met). Cows fed Smartamine had higher DMI, while cows fed Mepron had 
lower DMI compared to control cows. Supplementation of HMBTa and DL-Met did not affect 
DMI compared to control cows (Zanton et al., 2014). 
Responses to supplementation of RPMet and HMBi on DMI in the literature have been 
inconsistent. Kung and Rode (1996), Leonardi et al. (2003), and Chen et al. (2011) found that 
RPMet supplementation did not improve DMI. Limited studies have shown an increase in DMI 
with RPMet supplementation (Broderick et al., 2009; Zanton et al., 2014), whereas Ordway et al. 
(2009) and Zanton et al. (2014) reported decreases in DMI. Supplementation of HMBi may 
increase DMI (Osorio et al., 2014) because of the potential stimulatory effect of HMBi on 
cellulolytic bacteria and the subsequent increase in ruminal passage rate and DMI (Lee et al., 
2015).  
Lee et al. (2012b) assessed supplementation of RPMet products in MP-deficient diets. The 
authors reported that MP-deficient diets below 15% of the NRC requirements decreased DMI. 
However, the authors observed that a treatment supplemented with a combination of 3 RPAA 
consisted of Lys (100 g/cow), Met (30 g/cow), and His (50 g/cow) increased DMI (Lee et al., 
2012b). In contrast, Lee et al. (2015) found that supplementation with RPLys and RPMet in MP-
deficient diets (−256 to −305 MP g/d) did not affect DMI. Recent research suggests that 
transition cows may benefit from balancing for limiting EAA (Zhou et al., 2016). Supplementing 
Lys adequate diets with RPMet resulted in increases in DMI (Osorio et al., 2013; Zhou et al., 
2016). Improved DMI during the transition period leads to better postpartum performance in 




Responses to supplementation of NALM on feed intake is scarce, but a recent study by Liang 
et al. (2019) supplemented mid-lactating cows with 0, 15, 30, or 60 g/d of NALM. Dry matter 
intake was not affected by NALM supplementation. This finding is in agreement with Amaro et 
al. (2019), in which dosage rates of 0, 15, 30, and 45 g/d of NALM were fed to 60 multiparous 
Holstein dairy cows in early lactation (27 ± 4.3 DIM) and the dose did not affect DMI. However, 
a study by Gresenti (2017) supplemented mid to late lactating cows with 0, 15, 30, or 60 g/d of 
NALM. Increasing NALM supplementation linearly increased DMI, which the research group 
speculated may potentially be related to a linear increase in rumen MCP yield (Gresenti, 2017). 
However, the potential stimulatory effects of NALM supplementation on rumen microbiota 
needs to be further investigated. Contrasting results from Met supplementation may be due to 
differences in length of feeding of RPMet, varying Met supplementation amounts or rates (based 
on % DM), Met products, stage of lactation, or a combination of factors (Osorio et al., 2013). 
Research of RPLys and its effect on DMI is limited. However, RPLys supplementation does 
not appear to affect DMI of lactating dairy cows (Paz et al., 2014). These findings of RPLys and 
no effect of DMI are in agreement with Blauwiekel et al. (1997) and Robinson et al. (2011). 
Swanepoel et al. (2010) found that supplementation of RPLys did not influence DMI in mid-
lactation cows (77 ± 3.2 DIM). However, the late lactation group (262 ± 6.70 DIM) had a 
tendency toward lower DMI with addition of RPLys (Swanepoel et al., 2010). Recently, Girma 
et al. (2019) investigated providing transition cows with an increased level of energy and 
supplementing RPLys to improve both pre- and post-partal DMI. Supplementation of the TMR 
with RPLys improved DMI in postpartum cows and RPLys supplementation of the close-up diet 
increased DMI of cows compared to control animals (Girma et al., 2019). The authors contribute 




supplementation. The authors state that supplementing RPLys is an efficient strategy to increase 
the supply of Lys that serves as the carbon backbone for carnitine synthesis (Vaz and Wanders, 
2002; Robinson et al., 2006). Carnitine is the methylated form of Lys (Shug et al., 1982) that 
buffers acetyl residues from lipid mobilization, reduces ketone body formation, and plasma β-
hydroxybutyrate concentrations (Jacobs, 2002). Carnitine is important for oxidation of long-
chain fatty acids, regulation of ketosis, support of the immune system, and enhancement of the 
antioxidant system (Citil et al., 2009; Pirestani et al., 2011). As previously mentioned, DMI is 
controlled by many factors, so further research needs to be completed to fully understand RPAA 
(RPLys and RPMet) supplementation and DMI regulation. 
 
Effects on Milk Yield and Composition 
 
The adoption of the multiple component pricing system by the Federal Milk Marketing 
Administration (2000) changed the method by which producers are compensated for their milk. 
The system adjusted the pricing structure to pay producers based on the amounts of milk fat, 
protein and solids in milk. Milk was previously priced based on total fluid milk volume. 
Economically, milk protein and fat are the most important milk components to dairy farmers. As 
the value of milk protein continues to increase, there is greater interest among dairy farmers to 
find alternative feeding strategies such as RPAA supplementation to increase milk protein yields 
(Vyas and Erdman, 2009). Not only are productive responses important (i.e., increasing milk fat 
and protein yield), reducing environmental pollution by improving dietary N conversion into 
milk protein is of concern in the dairy industry (Lapierre et al., 2005). As mentioned previously, 




and milk protein yield model predictions, thus allowing modification of diets to increase post-
absorptive N efficiency and reduced N excretion by dairy cows.  
Encapsulated RPMet products, especially Smartamine and Mepron have been extensively 
studied in the literature (Patton., 2010). The evidence for one product being more effective than 
the other is inconclusive, as milk yield responses to supplemental RPMet products is variable. 
Patton (2010) reported increased milk production for both RPMet products (0.43 kg/d for 
Mepron and 0.14 kg/d for Smartamine) based on a meta-analysis from 36 studies with 17 studies 
evaluating Mepron and 18 evaluating Smartamine. Zanton et al. (2014) evaluated the lactational 
performance of dairy cows to supplemental Met sources. The authors assessed HMTBa provided 
as either a liquid or Ca salt form (17 papers with 34 control diets and 46 treatment comparisons), 
Mepron (18 papers with 35 control diets and 42 treatment comparisons), and Smartamine (20 
papers with 30 control diets and 39 treatment comparisons). Overall, milk yield did not respond 
to any form of Met supplementation; however, it tended to increase for HMTBa and Mepron 
supplementation (Zanton et al., 2014).  
Although there is variability in milk yield responses to supplemental Met products, strategic 
supplementation of RPAAs to low CP diets is becoming more popular. The observed production 
responses to supplementation of RPMet in cows fed low CP diets (i.e., MP-deficient diets) have 
been inconsistent and marginal (Arriola Apelo et al., 2014a; Sinclair et al., 2014). Milk yield was 
not improved when a low CP diet (15.0%) was fed alone or in combination with RPMet 
supplementation (Arriola Apelo et al., 2014b). However, further research with MP-deficient diets 
(ranging 5–10% below MP requirement) have sustained milk yield (Lee et al., 2015; Giallongo et 




performance. Osorio et al. (2013) and Zhou et al. (2016) found that cows supplemented with a 
RPMet source increased milk yield in the subsequent lactation.  
A Met analogue, HMTBa, is converted to Met in the body and used as a supplemental Met 
source in dairy production. Results of published studies assessing the effects of supplementing 
Met sources, including HMTBa, on performance variables are inconsistent as well. A recent 
meta-analysis was performed to summarize the accumulated results of HMTBa supplementation 
on animal performance (Feng et al., 2018). Supplementation of HMTBa had no effect on milk 
yield, which was in agreement with the meta-analysis done by Zanton et al. (2014). Noftsger et 
al. (2005) reported no difference in milk production when cows were supplemented with HMBi 
at 0.13% DM. However, St-Pierre and Sylvester (2005) showed an increase in milk yield (2.9 
kg/d) to cows supplemented with HMBi at 0.15% DM. Lee et al. (2015b) found that 
supplementing HMB (the unprotected form), numerically decreased milk production when % 
DM inclusion rate of dietary HMB increased. Alternatively, HMB supplementation increased 
milk production in a quadratic manner (Piepenbrink et al., 2004).  
Supplementation of NALM to mid lactation dairy cows improved milk yield in a quadratic 
manner, with 30 g/d of NALM seeming to be the optimal supplementation rate for milk yield 
under the experimental conditions (Liang et al., 2019). Amaro et al. (2019) found that milk yield 
of early lactation Holstein dairy cows tended to be greater (P = 0.07) with intermediate 
concentrations (15 and 30 g/d) of NALM compared to control animals. The authors noted that 
NALM supplementation at 30 g/d resulted in the highest milk yield (Amaro et al., 2019), which 
is in agreement with Liang et al. (2019). Encapsulated RPMet, Met analogues, and Met 
derivatives can impact milk yield, but their effects tend to be more prominent in altering milk 




Supplementing RPLys to pre-calving cows during the close-up period (-21 to 0 d) at a rate of 
40 g/cow/d had no effect on post-partum milk yield (Girma et al., 2019). These results agree with 
Swanepoel et al. (2010) who observed that supplementing dairy cows with RPLys (41 g/cow/d) 
did not affect milk yield in early lactation. Paz and Kononoff (2014) did not observe a difference 
in milk yield when RPLys was supplemented to diets with altering inclusion rates of low-fat 
distillers dry grains. Cows supplemented with RPLys (37 g/cow/d) after peak lactation showed 
no improvement in milk yield (Bernard et al., 2014). In contrast, Robinson et al. (2011) observed 
a 2 kg increase in milk yield when RPLys was supplemented to deliver 15 to 21 g of MP Lys. 
Historically, HMB/HMBTa and HMBi supplementation tends to exert their effects on milk 
fat production in lactating dairy cows (Zanton et al., 2014). Supplementation of HMTBa had no 
effect on milk yield, fat percent, protein percent, or protein yield, but increased milk fat yield 
(Feng et al., 2018). Zanton et al. (2014) reported HMTBa supplementation increased milk fat by 
5.38 g/g of MP Met from HMTBa, whereas Feng et al. (2018) reported HMTBa supplementation 
increased milk fat by 5 g/g of MP Met. A meta-analysis by Zanton et al. (2014) concluded 
HMTBa supplementation increases milk fat yield by 45 g/d and milk protein yield by 13 g/d. St-
Pierre and Sylvester (2005) observed a 166 g/d increase of milk fat yield with HMBi 
supplementation.  
The beneficial effects of HMTBa supplementation on milk fat have been investigated (Polan 
et al., 1970; Wang et al., 2010). Patton et al. (1970) reported that in vitro HMTBa 
supplementation can stimulate polar lipid formation and the authors suggest that the polar lipid 
class may increase with rumen protozoal growth. Increased ruminal biohydrogenation 
intermediates of the alternative pathway (e.g., trans-10 C18:1) exert antilipogenic effects in the 




2007). Baldin et al. (2018) witnessed that HMTBa supplemented to either high-producing (44.1 
± 4.50 kg/d) or low-producing (31.4 ± 4.30 kg/d milk yield) lactating dairy cows at 0.1% of diet 
DM maintained lower concentrations of the biohydrogenation intermediates, trans-10 C18:1 in 
milk samples. This finding suggests that HMTBa may stabilize ruminal biohydrogenation and 
help prevent the shift to the alternative biohydrogenation pathway (Baldin et al., 2018). 
Therefore, it is speculated that supplemental HMTBa exert their effects on milk fat production 
by shifting ruminal biohydrogenation intermediates. 
Physically encapsulated RPMet products and Met derivatives generally do not increase milk 
fat concentrations, because, unlike Met analogues, they lack a ruminal mode of action. However, 
encapsulated forms of RPMet have been shown to increase milk fat yield. Chen et al. (2011) 
found trends (P = 0.08) for increased milk fat concentration and yield when lactating dairy cows 
were supplemented with approximately 15 g of RPMet (Smartamine M) at 0.06% on a DM basis. 
Recently, Toledo et al. (2017) evaluated the effects of daily top-dressing a TMR with 21.2 g of 
RPMet from 30 ± 3.0 to 126 ± 3.0 DIM on productive performance in lactating dairy cows. The 
group found that top-dressing RPMet to multiparous cows increased milk fat percentages (3.45 
vs. 3.14%), although no effects were seen in primiparous cows. Based on limited data in the 
literature, NALM supplementation to either mid or early lactating dairy cows has failed to 
exhibit beneficial effects on milk fat concentrations (Amaro et al., 2019; Liang et al., 2019).   
Lactational performance of dairy cows in response to feeding RPLys has been researched 
over the past 30 yr, but sufficient data are lacking for beneficial effects of single AA 
supplementation of Lys in dairy rations. Supplementing combinations of Met and Lys is a much 
more common practice in the dairy industry. Swanepoel et al. (2010) reported reduced milk fat 




RPLys tablet to high-producing Holstein dairy cows (33.5 kg/d); milk protein concentration 
increased, while milk fat concentration and fat yield declined. However, according to Robinson 
(2010) the results described above for Lys supplementation on milk fat are inconsistent with the 
literature of post-ruminal Lys supplementation. A review of literature by Robinson (2010) 
reported that RPLys supplementation generally resulted in minimal negative DMI and 
production responses, possibly due to an AA imbalance or poor AA delivery to the intestinal 
absorptive site. Productive benefits of RPLys supplementation is disappointing and overall 
lactational performance effects can only be judged as negligible (Robinson, 2010).  
Less convincing evidence exists for the effect of L-Lys fed to lactating cows, but when L-Lys 
was deleted from a mixture of abomasal infused AAs, milk and milk protein production was 
reduced in the Lys-deficient infusion (Weeks et al., 2006). The exact relationship of L-Lys to AA 
deficiencies has yet to be established (Patton et al., 2014). However, increased L-Lys supply 
appears important in early lactation when microbial synthesis is reduced because of lower DMI, 
to help drive milk and milk protein production (Robinson et al., 2011). 
Although RPLys has minimal effects on production performance, increases in milk protein 
yield are one of the most likely observed responses due to supplementation with RPMet (Zanton 
et al., 2014). As previously described, Zanton et al. (2014) evaluated the lactational performance 
in dairy cows receiving supplemental Met sources (HMTBa, Mepron, and Smartamine) or post-
ruminal infusion of DL-Met. Milk protein yield was increased due to supplementation from all 
Met sources or from infusion of DL-Met and protein concentration was greater for all 
supplements or infusion of DL-Met, except for cows supplemented with HMTBa. Average milk 
protein yield responses ranged from 13 g/d for cows supplemented with HMTBa to 35 g/d for 




(2010) who noted similar milk protein production responses when cows were supplemented with 
RPMet (Mepron and Smartamine). Osorio et al. (2013) observed an increase in protein yield 
post-partal for cows supplemented with Smartamine and MetaSmart (1.24 and 1.23 kg/d) versus 
control cows (1.11 kg/d) during the transition period (-21 to 30 DIM). Supplementing RPMet can 
also result in an increase in milk protein percentage (Osorio et al., 2013), but one study 
(Benefield et al., 2009) reported a negative effect on milk protein concentration. Milk protein 
concentration has been used to indicate the effectiveness of a Met source, leading to changes in 
milk protein synthesis (Schwab et al., 2001). This is based on the idea that if milk yield is 
unchanged, an increase in milk protein concentration will allow for an inference to be made on 
milk protein yield and therefore efficacy of Met supplementation (i.e., bioavailability) (Zanton et 
al., 2014). The take-home message is that if Met can escape ruminal degradation and be made 
available post-ruminally, whether by supplementing RPMet products or Met analogues, milk 
protein can be increased. Methionine, if not utilized by the cow for milk and milk component 
production, can also potentially play a pivotal role in both cow and calf immunity. 
 
Effects on Immunity 
 
It is well-known that Lys and Met are the most limiting EAA for milk production, but these 
EAAs also play a crucial role in immune function. Methionine and its derivate metabolites (e.g., 
glutathione, taurine, polyamines) are immunonutrients in nonruminants (humans), which aid and 
improve immune functionality and activity (Vailati-Riboni et al., 2017). Recently, Vailati-Riboni 
et al. (2017) supplemented dairy cows with RPMet at 0.08% DM (8 to 12 g/d DL-Met) during 




vivo whole blood approach and the inflammatory response of the blood immune cells were tested 
with a LPS challenge (Vailati-Riboni et al., 2017). Overall, Met supplemented cows had a lower 
post-partum IL-1ß (pg/µL) concentration compared to the control cows. The Met treated cows 
had a greater phagocytosis capacity of neutrophils and oxidative burst activity by both 
monocytes and neutrophils. The authors suggest that the above results indicate that Met 
supplementation improved immune functional activity, while dampening the innate immune 
response to a LPS challenge (Vailati-Riboni et al., 2017). They also mention that Met probably 
acts on the oxidative status of the animal or indirectly through an immunologically active 
metabolite (e.g., taurine). Taurine is the most plentiful AA in the cytosol of neutrophils that can 
trap hypochlorous acid to form taurine monochloramine (Vailati-Riboni et al., 2017). Greater 
oxidative burst in neutrophils could be attributed to higher taurine monochloramine 
concentrations, leading to peri-partal immune cell hyper-responsiveness. Therefore, Met may act 
as an immunomodulator of the immune response in transition cows when cows undergo a period 
of immunosuppression (Vailati-Riboni et al., 2017). 
Zhou et al., (2017) investigated differences in liver functionality indexes (LFI) in peri-partal 
dairy cows fed RPMet or choline. The LFI is a composite index that is used to determine changes 
in plasma concentrations of blood biomarkers (albumin, cholesterol, and bilirubin) (Bertoni and 
Trevisi, et al., 2013). The researchers retrospectively assigned cows to low (LFI < 0) and high 
(LFI > 0) groups. Animals with a high LFI had greater liver functionality and are considered to 
be at a lower risk for developing health/metabolic disorders during the transition period. The 
liver regulates the metabolic activity aimed at mobilizing and directing nutrient flow to the 
mammary gland and the gastrointestinal tract (Seymour, 2016). Therefore, any reduction in liver 




(Seymour, 2016). A larger number of Met-supplemented cows were in the high LFI group. The 
high LFI cows had an overall greater liver functionality and decreased state of oxidative stress, 
indicating that the high LFI cows had a better immunometabolic status during the transition 
period (Zhou et al., 2017). 
In dairy cows, Met can also have a large impact on cow health through a variety of reasons 
other than immunomodulation or liver functionality (Figure 1). Methionine serves as a source of 
cysteine for glutathione synthesis via homocysteine produced in the Met cycle (Martinov et al., 
2009). Liang et al. (2019) supplemented RPMet to transition cows (-28 d to 30 d) at a rate of 
0.10% DM to determine if RPMet alters glutathione metabolism in peri-partal Holstein cows. 
Adipose tissue biopsies were collected on d −10, 10, and 30, relative to parturition, from 7 cows 
in each group to measure various proteins and genes related to glutathione metabolism. Overall, 
increased mRNA abundance of 4 key glutathione metabolism-related genes and upregulation of 
4 protein abundance components related to glutathione metabolism were found (Liang et al., 
2019). The authors state that RPMet supplementation may alter glutathione metabolism in 
adipose tissue (Liang et al., 2019). Altered glutathione metabolism in adipose tissue may 
contribute to reduced oxidative stress and inflammation during the transition period. However, 
further research is needed to assess the impacts of adipose tissue glutathione metabolism on 
immunity of dairy cattle. 
Methionine plays a role in the liver as a lipotropic agent (Martinov et al., 2009). Methionine 
is needed for synthesis of SAM, which is a key methyl donor necessary for the packaging of very 
low-density lipoproteins (VLDL) for exportation out of the liver (Osorio et al., 2014). 
Triglycerides, if not exported from the liver, can accumulate causing fatty liver disease in 




plasma VLDL concentrations in post-partum transition cows supplemented with RPMet. This 
finding suggests that Met may affect hepatic lipid metabolism and exportation of VLDLs from 
the liver (Sun et al., 2016).  
Transition cows benefit from Met supplementation through lipotropic agent activity, 
antioxidant substrate formation, immunomodulation and immune functionality. In addition, 
maternal nutritional status may also benefit neonatal innate immune function (Jacometo et al., 
2016). Abdelmegeid et al. (2017) performed an in vitro study with neonatal Holstein calf 
polymorphonuclear leukocytes (PMNL). Supplementation with either Met, choline, or taurine 
altered the inflammatory response and affected oxidative stress, suggesting that Met and other 
nutrients may be needed for an adequate immune response in calves (Abdelmegeid et al., 2017). 
Jacometo et al. (2018) supplemented RPMet at 0.08% DM during the close-up period to 
multiparous Holstein cows. Calves born to RPMet supplemented cows showed positive changes 
in PMNL molecular pathways compared to control calves. Although the data are inconclusive, 
maternal RPMet supplementation may play a role in neonatal calf immunity, but further research 
is needed to identify the link between maternal AA supply and calf immunity.  
Methionine’s role in ruminant immunity has been investigated more extensively in the 
literature compared with that of Lys. However, Lys deficiency can impair both antibody 
responses and cell-mediated immune responses in monogastric animals (Chen et al., 2003; Wu, 
2013). Lysine deficiency limits animal immunity-related protein synthesis which includes 
antibodies and cytokines that are necessary for normal immune function (Liao et al., 2015). Han 
et al. (2018) reported that Lys deficiency in piglets impaired inflammatory responses in the liver, 
kidney, and spleen by mediating serum antibody concentrations (i.e., IgG and IgM) and 




inflammatory response were altered by Lys restriction in piglets (Han et al., 2018). It is apparent 
that Lys is necessary for immune function in monogastrics (i.e., humans, swine, and fowl), but 
data are lacking for the potential beneficial effects of Lys in ruminant immunology.  
 
Intestinal Absorption of AA 
 
The absorption of AAs through the gastrointestinal tract of animals is an important biological 
function because growth, lactation, reproduction, and maintenance requirements depend on the 
adequate supply of AAs for protein synthesis. Amino acids that reach the small intestine can be 
incorporated into proteins, converted into other AA for biosynthetic processes, oxidized to CO2, 
or transported through enterocytes into the mesenteric portal vein (Stoll and Burrin, 2006). 
Protein reaching the small intestine of the ruminant can come from a variety of sources: 
including rumen undegradable protein (RUP), MCP, and endogenous proteins. Ruminants use 
similar intestinal and pancreatic proteases as monogastric animals for protein breakdown. 
Absorption rates of AAs differ by anatomical location of the small intestine (i.e., duodenum, 
jejunum, and ileum), enterocyte maturity, and the site of AA absorption varies by species. In 
monogastrics, the jejunum is believed to hold the greatest capacity for AA absorption (Webb, 
1990). In ruminants, the majority of AA absorption increases with distance from the pylorus and 
the majority of absorption occurs in the jejunum and ileum (William, 1969; Phillips et al., 1976). 
Amino acid absorption site and rate can also be influenced by individual AA. Williams 
(1969) observed that sheep absorbed the majority of their AAs in the ileum; however, the order 
of absorption varied with anatomical location, suggesting that AA affinities for transport systems 




and valine absorption occurs in the ileum and Met absorption was similar between the jejunum 
and ileum in sheep. Webb (1990) reported that total Met and Lys uptake was higher by ileal 
brush border membrane vesicles than by jejunal brush border membrane vesicles. Webb (1990) 
also reported that in ileal and jejunal tissue, Met transporters had lower affinities and higher 
capacities for Met than the Lys transporter. This suggests that the mode of transportation and 
mechanism of AA transport through the enterocytes can differ according to the individual AA 
being absorbed. 
Amino acid transport is affected by size, charge, and AA structural configuration (i.e., R-
group side chains). Spencer et al. (1962) suggested that all transport carriers require the presence 
of an amino/imino group and a carboxyl group. Hydrophilic small weight neutral amino acids are 
taken up less readily than the larger weight hydrophobic amino acids and basic amino acid 
transport is intermediate (Webb, 1990). The various carriers are located on the basolateral 
membrane, brush border, or on both sides of the small intestine (Webb, 1990). To date many AA 
transport systems have been identified in the small intestine. However, the exact number is 
unknown, but the classification of amino acid transport systems is based on substrate preference 
and is determined by kinetic and inhibition analysis measurements (Christensen, 1984). 
The major mechanisms for AA transport from the intestinal lumen to the enterocytes occur 
through simple diffusion, facilitated diffusion, or active transport (Wilson and Webb, 1990).  
Active transport requires energy and is believed to be Na+-dependent, while facilitated diffusion 
mechanisms are Na+-independent systems. The relative significance of each route is highly 
dependent on the concentration of substrate present. The Na+-dependent systems require 
metabolic energy to transport AAs against a concentration gradient. The Na+ gradient which has 




located in the basolateral membrane of the enterocyte (Webb, 1990). The Na+/K+-ATPase pump 
co-transports Na+ and an AA into the cell and K+ out of the cell (Webb and Matthews, 1994). 
The Na+-independent systems do not require metabolic energy to move along a concentration 
gradient. Simple diffusion is the predominant form of transport, but when substrate 
concentrations are low, facilitated diffusion and active transport will account for more transport 




Metabolism of Met is divided into 3 pathways: transmethylation, remethylation, and 
transsulfuration. Transmethylation is a sequence of reactions present in Met metabolism and is 
universally present in cells. Transmethylation (i.e., Met metabolism) begins when Met is 
converted to SAM by Met adenosyltransferase (Brosnan and Brosnan, 2006). Numerous 
methylases comprise the user group for SAM that donates its methyl group to an acceptor to 
produce S-adenosylhomocysteine (Brosnan and Brosnan, 2006). The S-adenosylhomocysteine is 
hydrolyzed to adenosine and homocysteine in a reaction catalyzed by S-adenosylhomocysteinase 
(Martinov et al., 2009).  
Remethylation occurs when homocysteine is methylated back to Met by Met synthase, which 
is ubiquitous in the body (Brosnan and Brosnan, 2006). Betaine homocysteine methyltransferase 
which is present in the liver and kidneys of some species can also methylate homocysteine to 
Met. Methionine synthase uses 5-methyl-tetrahydrofolate as a methyl donor, while betaine 
homocysteine methyltransferase uses betaine, from the diet or betaine produced during choline 




affect remethylation. The combined steps of transmethylation and remethylation makeup what is 
called the Met cycle and these steps occur in most cells of the body (Brosnan and Brosnan, 
2006). Methionine catabolism does not occur during transmethylation or remethylation.  
In the transsulfuration pathway, homocysteine is converted to cysteine by cystathionine β-
synthase and cystathionine γ-lyase. The transsulfuration pathway exists in most tissues except 
muscle (including heart) and endothelium (Martinov et al., 2009). The conversion of Met to 
cysteine is an irreversible process. Methionine metabolism plays a vital role in folate 
assimilation. Methionine synthase converts 5-methyl-tetrahydrofolate to tetrahydrofolate, 
making it free to support DNA synthesis and various biological functions (Brosnan and Brosnan, 
2006). The transsulfuration pathway is responsible for the majority of Met catabolism in the 
body. The transsulfuration is also vital for the production of glutathione and taurine through its 
synthesis of cysteine. Glutathione synthesis is often limiting based on cellular cysteine 
concentrations and the transsulfuration pathway provides half of the cellular cysteine 
requirements (Mosharov et al., 2000).   
It is important to remember that Met metabolism is dependent upon the availability of 
coenzymes and enzymes. For animals to properly metabolize Met, dietary requirements for 
vitamins and minerals must be met. Dietary intake of B vitamins, specifically B2, B9, and B12 
are necessary for proper Met metabolism in the body. Methionine synthase uses the derivative of 
vitamin B9 (folic acid), using 5-methyl-tetrahydrofolate as a methyl donor. 5-methyl- 
tetrahydrofolate donates a methyl group to homocysteine to regenerate Met and the enzyme Met 
synthase catalyzes this step and utilizes vitamin B12 (cobalamin) as a cofactor (Locasale, 2013). 
Vitamin B2 (riboflavin) is a cofactor for 5-methyl-tetrahydrofolate synthesis. In monogastrics, 




synthesize B vitamins, ruminants are usually able to meet B vitamin requirements once rumen 
microbes reach the small intestine (NRC, 2001). 
 
Mammary Gland AA Metabolism 
 
Knowledge of mammary gland AA metabolism is just as important as body or hepatic AA 
metabolism, as the mammary gland is responsible for milk protein synthesis and can impact 
lactational performance. Historically, AA metabolism is classified by the balance between 
arteriovenous uptake and milk casein-AA secretion (Manjarin et al., 2014), while catabolism is 
represented by excessive AA uptake which is not available for milk protein synthesis. Complex 
intracellular interactions exist within mammary tissue. Therefore, AA metabolism in the 
mammary gland may give insight on mechanisms responsible for improved AA utilization in 
lactating dairy cows. Thus, if molecular mechanisms can be targeted by AA supplementation, 





Lysine has one of the highest fractional extraction rates by the mammary gland in bovids, 
ovids, and suids (Trottier et al., 1997; Mabjeesh et al., 2000; Manjarin et al., 2014). The primary 
metabolic fate of Lys in the mammary gland is for milk protein synthesis. Mabjeesh et al. (2000) 
described that the uptake of Lys in the mammary gland of dairy cows and goats is greater than 




mammary tissue. Lapierre et al. (2009) assessed the responses to mammary and splanchnic 
metabolism to altered Lys supply in dairy cows. Six catheterized dairy cows received a control 
diet with low CP (15.0% DM) plus an abomasal infusion of AAs (560 g/d) without or with Lys 
(at 50.3 g/d) (Lapierre et al., 2009). The researchers found that limiting Lys did not alter the 
uptake of Lys by the mammary gland. The mammary uptake to milk output ratio of Lys 
decreased from 1.37 to 1.12 without Lys in the infusion, but Lys was still in excess of mammary 
supply (Lapierre et al., 2009). The excessive uptake of Lys points toward Lys serving roles, other 
than milk protein synthesis. The swine NRC (2012) estimates the rate of post-absorptive Lys 
utilization into milk protein to be 67%, leaving 33% of Lys to be utilized for other processes, 
including oxidative losses (Manjarin et al., 2014). According to Manjarin et al., (2014), Lys must 
be involved in other roles, such as utilization of Lys into nonessential AA synthesis and the 





Methionine extraction by the mammary gland, unlike Lys, closely matches the amounts 
required for milk protein synthesis (Bequette et al. 1998). Methionine, as previously stated has 
many biological functions (Figure 1) and Met can be utilized to synthesize phospholipids, 
carnitine, creatine, and polyamines (Wu, 2013a). To date there is a clear deficit in the literature 
on the understanding of Met’s role in mammary tissue except for its incorporation into milk 
proteins (Manjarin et al. 2014). According to Manjarin et al. (2014), none of the catabolic 




mammary tissue. The swine NRC (2012) used a coefficient of utilization efficiency for Met of 
66%. The utilization efficiency for Met of 66% is most likely underestimated based on the idea 
that mammary extraction of Met matches the amount required for milk protein output in ovids 
and suids (Bequette et al. 1998; Manjarin et al., 2014). Guan et al. (2004) estimated the 
efficiency of Met incorporation into porcine milk protein as being closer to 95%. Lysine and Met 
catabolic pathways in mammary tissues need to be further investigated in cattle to get a better 
understanding of the function these EAAs play in the mammary gland and on lactation.  
 
Mammalian Target of Rapamycin (mTOR) Pathway 
 
The mammalian target of rapamycin (mTOR) pathway regulates cell cycle progression, cell 
growth, and protein synthesis through its ability to integrate nutrient and growth factor signals to 
increase protein translation (Manjarin et al., 2014). The effect of individual AA supplementation 
on translational protein synthesis has become an important research focus in recent years. The 
mTOR pathway in the mammary gland has been fully described, but the molecular mechanisms 
that AA influence for mTOR activation to increase protein synthesis in monogastrics and 
ruminants is unclear (Manjarin et al., 2014). It is believed that AA availability regulates the 
mTOR signaling pathway, by controlling translational initiation rates and by suppressing the 
inhibitory activity of eIF4E binding protein 1 (Arriola Apelo et al., 2014a). Amino acids may 
also increase elongation rates by stimulating eukaryotic elongation factor 2 and enhance 
ribosomal activity through activation of ribosomal protein S6 (Arriola Apelo et al., 2014a). 
Eukaryotic elongation factor 2 has been thought to be a limiting factor for milk protein synthesis 




Recently, Ma et al. (2019) sought to evaluate the effect of supplementing RPMet around 
parturition on the quantity and phosphorylation of mTOR related signaling proteins in post-partal 
bovine mammary tissue. The researchers found lower phosphorylation of mTOR complex 1 and 
were unable to find the exact mechanisms responsible for increased protein synthesis due to 
RPMet supplementation (Ma et al., 2019). However, they attributed the increased milk protein 
percentage post-partal to increased DMI which may increase AA flux into the mammary gland. 
Increased protein synthesis could also be attributed to increases in AKT serine/threonine kinase 1 
phosphorylation status and a cascade of intracellular events, leading to upregulation of AA and 
glucose transporters (Ma et al., 2019). It is evident that the exact molecular mechanisms that AA 
influence for mTOR activation is unclear and further research needs to be conducted. The 
findings from such studies could lead to a better understanding of why production responses to 
supplementation of RPAAs are inconsistent and how molecular mechanisms could potentially 




Current Approaches and Limitations 
 
Bioavailability of AA in dairy cows has been assessed in vivo by a few techniques which 
include the production response approach (Schwab et al., 2001; Fleming et al., 2019), the area-
under-the-curve method (Graulet et al., 2005; Fleming et al., 2019), the plasma free AA dose-
response technique (Rulquin and Kowalczyk, 2003; Borucki Castro et al., 2008; Hanigan et al., 




most recent technique described in the literature is the stable isotope-based approach which is 
used for the assessment of intestinally absorbed AAs from individual feed ingredients (Estes et 
al., 2018). Although each approach has been described in the literature, caution should be taken 
when reviewing each BA method, because each approach has limitations as is discussed below. 
The major limitation for the production response approach is being able to ensure an AA 
deficiency, for all treatment animals on the trial, over the entire range of the treatment dosages 
(Whitehouse et al., 2017). The complexity of AA interactions in the mammary gland, 
specifically with the mTOR pathway, also limits the utility of the production response approach. 
If animals respond to AA supplementation with a positive linear response in milk protein 
concentration or yield, this could either be due the AA exerting its effect directly in the 
mammary gland, through activation of a molecular pathway, or nutrient interactions to stimulate 
milk protein synthesis. The AA deficiency is necessary in order to obtain a linear response to AA 
supplementation in either milk protein concentration (%) or milk protein yield (kg/d) 
(Whitehouse et al., 2017).  
For the area-under-the-curve technique, animals receive a single pulse dose of the RPAA in 
high quantities not normally encountered by rumen microbes, which may limit or alter the 
ruminal RPAA degradation, thus affecting the amount of AA that reaches the small intestine for 
absorption (Whitehouse et al., 2017). The limitation for the plasma dose-response technique was 
that all trials that used this technique, prior to the revised Lys technique, failed to assign dietary 
treatments simultaneously within the same Latin square, thus ignoring potential animal variation 
(Whitehouse et al., 2017).  
A stable isotope non-invasive method for measuring BA of AA has been studied in ruminants 




either utilize a bolus or constant rate infusion of the AA isotope of interest (Estes, 2016). The 
isotopic measurements are used to estimate the total AA flux from the labeled AA infused 
dosage and subsequent isotopic enrichment of the samples selected to represent the compartment 
(i.e., pool) of interest (Estes, 2016). The bolus approach uses a single isotope dose delivered into 
the compartment of interest (Estes, 2016). The constant infusion approach uses a similar 
principal, but the infusion is continued until enrichment in the compartment of interest reaches a 
steady state to calculate a rate of total entry into the compartment (Estes, 2016).  
Borucki Castro et al. (2008) assessed the efficacy of a whole-body Lys net flux method to 
determine BA of Lys in dairy cows fed 3 different forms of soybean meal. The whole-body net 
flux method (i.e., isotopic method) was tested against the plasma dose-response technique and 
duodenal flow/intestinal digestion method. Borucki Castro et al. (2008) found that the plasma 
response method recovered 97% of the omasally infused Lys and the isotope method recovered 
100% of the omasally infused Lys, suggesting that there was no loss of the infused dose. The 
researchers concluded that the isotope method is sensitive and accurate in determining Lys 
availability in dairy cattle, which could be beneficial in eliminating the use of cannulated animals 
for BA studies (Borucki Castro et al., 2008). However, the plasma response curve yielded similar 





For RPMet products, the BA is generally calculated based on a positive or negative dietary 




80%. However, the equation to derive BA of AA will be dependent on the method used to 
measure BA (e.g., production response approach, the area-under-the-curve method, the plasma 
free AA dose-response technique, or the stable isotope-based approach). Before a reference BA 
value for Smartamine M was established, Berthiaume et al. (2000) stated that RPMet BA should 
be based on a product’s AA concentration, ruminal stability, and intestinal digestibility. Koenig 
and Rode (2001) defined BA of RPMet as a combination of effective ruminal degradability and 
intestinal disappearance with the calculation being equal to: (100 – effective ruminal 
degradability) × intestinal digestibility. Koenig and Rode (2001) estimated the BA of Mepron to 
be a 23.6% based on the above calculation. Recently, Abdi-Benemar (2016) reported a BA of 
61% for Mepron, which is closer to that of Smartamine M.  
Bioavailability of Smartamine M was first estimated to be 80% from nylon bag studies and 
determination of its ruminal stability exceeding 90% at 24 h and intestinal release values close to 
90% (Schwab and Ordway, 2003). Robert and Williams (1997), estimated that the BA of 
Smartamine M falls somewhere between 75 to 97%, with an average BA value of 88%. Graulet 
et al. (2005) determined the BA of Smartamine M to be 74%, while Schwab (1995) found the 
BA to be 80%. 
The BA of HMBi is between 40 and 58%, based on blood kinetics (Robert et al., 2001; 
Robert et al., 2002) and milk true protein indices (Schwab et al., 2001). Bioavailability 
determined by blood Met concentration was 53 and 74% for HMBi and Smartamine M (Graulet 
et al., 2005). The measurements from Graulet et al. (2005) indicate BA of HMBi to be 71% of 
that from Smartamine M, whereas another study indicated that BA of HMB was 50% of that of 







Limited data is available in the literature on the BA of RPLys products. However, the most 
studied RPLys product is AjiPro-L and multiple generations of AjiPro-L have been developed 
(i.e., generations 1-3). Recently, Whitehouse et al. (2017) estimated the BA of AjiPro-L 2G and 
AjiPro-L 3G using the plasma free Lys dose-response method. The slope for the AjiPro-L 3G 
was numerically greater than that for the AjiPro-L 2G, which resulted in a 12% improvement in 
the BA (Whitehouse et al., 2017). Tucker et al. (2015) compared the BA of 3 commercially 
available RPLys products using the plasma free Lys dose-response method (MetaboLys; H.J. 
Baker & Bro., Inc., Westport, CT and Lysine USA; Kemin Industries Inc., Des Moines, IA 
against the second generation AjiPro-L; Ajinomoto Heartland, Inc.). The BA of MetaboLys and 
Lysine USA were estimated as 18.3 and 38.2% of the second generation AjiPro-L BA, 




Methionine and Lys are recognized as the 2 most limiting AA for milk protein synthesis and 
milk production in dairy cows. With this in mind, considerable advancements have been made in 
both protein and AA nutrition of dairy cows. These include the development of RPAA sources 
with varying encapsulation coatings, the development of Met analogues, and the development of 
cost-effective Met and Lys derivatives. As prices of feed protein continue to rise and as 
environmental issues remain a concern, producers and nutritionists will need to evaluate the 




multiple limiting AA concept in an animal requirement model will likely add to the complexity 
of feeding dairy cattle. Although not necessary for animal requirement models, molecular and 
cellular mechanisms (i.e., mTOR pathway) can identify sources of variation in response to AA 
supplementation of dairy cows and potential discrepancies in BA data. A sound approach to 
determine BA of AA in lactating dairy cattle may not be practical, but the prospect of an in vivo 
stable isotope-based method could help with precision feeding of cattle.  
There is an overall insufficiency of information on Met and Lys derivatives in lactating 
cattle. The dissertation emphasis will be on Met (NALM) and Lys (NALL) acetylated derivatives 
supplemented to lactating dairy cows. Their impacts on lactational performance (NALM and 
NALL) and BA of NALM in lactation cows will be assessed. It was hypothesized that increased 
Met and Lys supply from the AA derivatives being fed (NALM and NALL) would improve 
lactational performance by increasing milk yield; however, the degree of response would depend 
upon the AA derivative supplemental dose in the dietary treatments. It was anticipated that 
NALM will act as an effective source for delivering BA Met equivalents to the small intestine to 
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Figure 1. Biological functions of Met and hepatic Met metabolism. BHMT = Betaine-
homocysteine methyltransferase; CBS = cystathionine-β-synthase; CSE = cystathionase; DMG = 
dimethylglycine; GSH = glutathione; GNMT = glycine N-methyltransferase; HCY = 
homocysteine; MAT1A = Met adenosyltransferase 1A; MTR = Met reductase; MT = 
methyltransferase; 5-MTHF = 5-methyltetrahydrofolate; SAH = S-adenosylhomocysteine; 
SAHH = SAH hydrolase; SAM = S-adenosyl-Met and THF = tetrahydrofolate. Adapted from 















CHAPTER 1  
 
Influence of supplementing a methionine derivative, N-acetyl-L-methionine in dairy diets 
on production and ruminal fermentation by lactating cows during early to mid-lactation   




The present study investigated production responses and ruminal fermentation characteristics 
of lactating dairy cows when supplemented with N-acetyl-L-Met (NALM) as a source of rumen-
protected Met in metabolizable protein (MP) -deficient (MPD) or MP-adequate diet (MPA). 
Eight lactating dairy cows (53  10.4 d-in-milk, on average) were blocked by parity and days-in-
milk, and the experiment was performed in a replicated 4 × 4 Latin square design. Within each 
square, cows were randomly assigned to a sequence of 4 diets during each of the four 21-d 
periods (14 d of treatment adaptation and 7 d of data collection and sampling). A 2 × 2 factorial 
arrangement was used; MPD or MPA was combined without or with NALM: MPD without 
NALM, MPD with NALM (MPD+NALM), MPA without NALM, and MPA with NALM 
(MPA+NALM). A NALM product was supplemented in the MPD+NALM and the 
MPA+NALM at 30 g/cow/d. Supplementation of NALM did not affect dry matter intake (DMI) 
and milk yield regardless of MP concentration. In addition, supplementing NALM resulted in a 
similar milk true protein concentration and yield. In contrast, NALM supplementation increased 
milk fat concentration and yield and 3.5% fat-corrected milk (FCM) yield and tended to increase 




observed for increased 3.5% FCM yield/DMI and ECM yield/DMI, and the positive effects were 
greater under the MPA than the MPD diet, resulting in trends toward interactions between MP 
and NALM. Dietary treatments had similar effects on ruminal fermentation characteristics and 
microbial protein yield. Plasma concentration of Met increased under the MPD but not the MPA 
diet, leading to an MP × NALM interaction. Overall results in the current study suggest that 
NALM exerted minor influence on ruminal metabolism, but increased milk fat concentration, 
resulting in increases in milk fat yield and feed efficiency. Yet, potential effects of NALM on 
intermediary metabolism between the gastrointestinal tract, the liver, and the mammary gland 
need to be explored to understand utilization efficiency for production of dairy cows.         





Dietary sources of N in lactation diets are inefficiently utilized by dairy cows, as they excrete 
substantially more N in manure over milk, which increases milk production costs and 
environmental N excretion (Noftsger et al., 2005). Optimizing the balance of total AA in MP has 
been used as the most promising means to maximize lactational performance with minimal 
dietary CP supply (Lee et al., 2012a). Studies have suggested that Lys and Met are the most 
limiting AA, especially in high producing dairy cows fed alfalfa and corn silage-based 
commercial diets typically used in the United States, and optimal concentrations of these limiting 
AA in MP are required to increase milk protein synthesis (Schwab et al., 1976). Thus, balancing 




production. With an increasing economic value of milk protein, there has been strong interest by 
dairy producers and industries in nutritional modifications such as supplementation of rumen-
protected AA that will increase milk protein yield (Arriola Apelo et al., 2014a).  
Considerable research has been conducted over the past 3 decades to develop technologies to 
protect AA from ruminal degradation, and consequently ruminally protected Met (RPMet) 
products in different chemical forms have been developed and extensively used to alleviate Met 
deficiencies in lactating dairy cows (Overton et al., 1998; Patton, 2010). However, attempts to 
increase milk protein yield by increasing the supply of Met by addition of RPMet have given 
mixed results mainly due to complex inter-organ metabolisms in the rumen, the liver, and the 
mammary gland (Bequette et al., 2003) and substantial variations on DMI and CP concentration 
in feeds (Sinclair et al., 2014; Zanton et al., 2014).  
The N-acetyl-L-Met (NALM) is a Met derivative produced via protection of L-Met α-amino 
group with an N-acetyl group. The cost of production for N-acetyl DL-Met by addition of an α-
amino N-acetyl group to DL-Met is economically infeasible, but a cost-effective method for 
NALM production was recently developed (CJ CheilJedang, Seoul, South Korea) by addition of 
an α-amino N-acetyl group to L-Met. The NALM has been shown to be bioavailable and capable 
of replacing dietary Met in animals and humans according to Rotruck and Boggs (1975). In 
addition, NALM was readily incorporated into tissue proteins and supported growth of rats 
(Rotruck and Boggs, 1975). The NALM has also been used in foods as an approved food 
additive (Baxter et al., 2002). Windschitl and Stern (1988) reported that Met flowing out of 
continuous cultures increased with N-acetyl DL-Met administration without a change in bacterial 




degradation. In the literature, however, there is no research reported on the effects of 
supplementing NALM in lactation diet on production and ruminal fermentation in dairy cows.  
We conducted the present study to investigate lactational performance and nutrient utilization 
by lactating dairy cows supplemented without or with NALM in MP-deficient (MPD) or MP-
adequate diet (MPA), according to NRC (2001). We hypothesized that increased Met supply 
from NALM would increase milk protein synthesis and milk yield, but the degree of the response 
would depend upon the MP supply in the diets. 
 
MATERIALS AND METHODS 
 
The dairy cows used in the present study were cared for according to the Live Animal Use in 
Research Guidelines of the Institutional Animal Care and Use Committee at Utah State 
University. The study was conducted at the Caine Dairy Research Center (Wellsville, UT), Utah 
State University from May to July, 2016. 
 
Cows, Experimental Design, and Diets 
 
Eight multiparous lactating Holstein cows were used during this trial. Cows began the 
experiment averaging 53 ± 10.4 DIM, producing 39.2 ± 5.13 kg/d of milk yield, consuming 24.2 
± 3.51 kg/d of DMI and an average BW of 696 ± 66.2 and 721 ± 57.3 kg at the beginning and the 
end of the experiment, respectively. The experiment was performed in a replicated 4 × 4 Latin 
square design. Within each square, cows were randomly assigned to a sequence of 4 diets during 




sampling). Although primary production parameters were measured in the present study, caution 
needs to interpret the data due to the short-term observation. Within each square, cows were 
randomly assigned to a sequence of 4 dietary treatments with a 2 × 2 factorial arrangement: MPD 
without NALM diet (MPD−NALM); MPD with NALM diet (MPD+NALM); MPA without 
NALM diet (MPA−NALM), and MPA with NALM (MPA+NALM; Table 1-1).  
The developmental NALM product from CJ CheilJedang was used as a supplemental source 
of RPMet in this study. The NALM product was in powder form, and contained Met 
concentration of 78.0%, with 99.5% purity. The NALM product was added at a rate of 0.13% 
DM, and the rate was determined for cows to consume 30 g/cow/d of Met in order to supply 15.6 
g of digestible Met to the small intestine according to manufacturer’s recommendation. This rate 
was also based on the requirements of digestible Met for cows fed the MPD diet. The 
recommendation of required digestible Lys and Met were assumed as 6.6 and 2.2% of the MP 
requirements, respectively (NRC, 2001). The NALM product was top-dressed onto 
corresponding experimental diets. 
The chemical composition of alfalfa hay was 21.6, 38.9, and 27.9% DM for CP, NDF, and 
ADF, respectively, whereas corn silage contained 5.32, 41.5, and 23.9% DM for CP, NDF, and 
ADF, respectively. The diets had a forage-to-concentrate ratio of 61:39 (DM basis) on average 
and were typical of high-producing dairy cows in the Intermountain West (i.e., Utah, Idaho, 
Wyoming, Montana, and parts of Arizona and Nevada) with 44% of the forage coming from 
good-quality alfalfa hay. Diets were formulated based on the NRC (2001) recommendations to 
provide sufficient NEL, MP, vitamins, and minerals with an estimated intake of 25.0 kg/d to 




Cows were housed individually in tie stalls fitted with rubber mattresses covered with straw, 
allowing free access to water. Cows were individually fed twice daily for ad libitum intake at a 
level of 110% expected daily intake with 70% of allotted feed fed at 0600 h and 30% fed at 1500 
h. Feed offered and refused was recorded daily, and samples were taken during the sampling 
week to determine DMI. Cows were milked twice daily at 0400 and 1600 h, and milk production 
was recorded throughout the entire experiment.  
 
Energy Partitioning Calculations 
 
Energy partitioning was determined during treatment periods using data of milk yield, milk 
composition, and BW of experimental animals. Cows were weighed for 2 consecutive d after the 
a.m. milking and before the a.m. feeding at the beginning (d 1 and 2) and end (d 20 and 21) of 
each period. These weights were used to calculate the mean BW of cows for each experimental 
period. Energy used for maintenance was calculated as BW0.75× 0.08 (NRC, 2001). Energy of 
BW change was assumed to be 5.114 Mcal/kg of gain or 4.924 Mcal/kg of loss (NRC, 2001). 
Milk energy was calculated as (0.0929 × milk fat concentration) + (0.0563 × milk true protein 
concentration) + (0.0395 × milk lactose concentration) (NRC, 2001). Estimated NEL value was 
calculated by total net energy utilization (maintenance, BW gain, and milk) divided by DMI 
(Neal et al., 2014).  
 





Samples of alfalfa hay and corn silage were taken weekly to determine DM, and diets were 
adjusted accordingly for change in DM concentration. Samples were composited by month, 
ground to pass a 1-mm screen (standard model 4; Arthur H. Thomas Co., Swedesboro, NJ), and 
stored for chemical analysis. Samples of TMR and orts were collected from individual cows on d 
15 to d 21, composited, dried at 60°C for 48 h, and ground as previously described. The DM 
concentrations of samples were used to calculate intakes of DM and nutrients. 
Analytical DM concentration of samples was determined by oven drying overnight at 105°C, 
and OM was determined by ashing at 550°C for 5 h (AOAC, 2000; method 942.05). 
Concentration of CP was determined using an automated N combustion analyzer (Elementar, 
Analysensysteme GmbH, Hanau, Germany; AOAC, 2000; method 968.06). Concentrations of 
NDF and ADF were sequentially determined using a fiber analyzer (200/220, ANKOM 
Technology, Macedon, NY) according to the methodology supplied by the company, which is 
based on the methods described by Van Soest et al. (1991). Sodium sulfite was used in the 
procedure for NDF determination and pre-treated with heat-stable amylase (Type XI-A from 
Bacillus subtilis; Sigma-Aldrich Corporation, St. Louis, MO). Ether extract was measured using 
a fat analyzer (XT20, ANKOM Technology; AOAC, 2000; method 2003.05). In addition, 
samples of TMR were analyzed for starch by Dairyland Laboratories, Inc. (Arcadia, WI) 
according to Knudsen (1997).  
Milk was sampled for 2 consecutive days (d 15 and 16) during the a.m. and p.m. milkings 
each period. Individual milk samples were analyzed by the Rocky Mountain DHIA Laboratory 
(Providence, UT) for fat, true protein, lactose, and MUN. Milk composition was expressed on 




multiplying milk yield from the respective day by fat and true protein concentration of the milk 
from an individual cow. 
 
Blood and Urine Samplings and Analyses 
 
Blood samples were collected immediately before the morning feeding as well as at 1000 and 
1400 h into 10-mL plasma vacuum tubes from the coccygeal artery or vein on d 19 and 20 in 
each period. Blood samples were centrifuged at 2,300 × g for 20 min, and plasma was collected 
and stored at ‒40°C for subsequent AA analysis. The plasma samples were prepared for AA 
analysis using the EZ:faast GC-FID Free (Physiological) Amino Acid Analysis Kit (Phenomenex 
Inc., Torrance, CA). Concentrations of plasma free AA were determined in accordance with the 
user manual provided with the kit. Extraction of free AA from the plasma consisted of a 
combination of solid-phase extraction, derivatization, and liquid/liquid extraction. The organic 
phase containing the AA in question were analyzed using a GC (model 5890, Hewlett-Packard 
Lab) with a capillary column (30 m × 0.32-mm i.d., 1-μm phase thickness, Zebron ZB-FAAP; 
Phenomenex Inc., Torrance, CA) and flame-ionization detection. 
On d 15 to 17, spot urine samples were collected from each cow at 0600 and 1800 h for a 
total of 6 samples per cow (Holt et al., 2013). Using 4 M HCl urine samples were acidified to pH 
< 4.0 and composited by cow per period. Samples were frozen and stored at –40°C. At a later 
date, the samples were thawed in preparation for analysis and diluted with 39 parts diluent to 1 
part urine. The diluent utilized consisted of 0.202% sodium 1-heptanesulfonate and 0.086% 
ammonium dihydrogen phosphate (NH4H2PO4). The solution was brought to a pH of 2.1 using 4 




way to estimate the microbial protein (MCP) flow to the duodenum (Shingfield and Offer, 
1998). The PD and creatinine were analyzed using an HPLC instrument (Waters Corp., Milford, 
MA) according to the procedures set forth by Shingfield and Offer (1999). In order to estimate 
urine volume, creatinine was used as a marker (Valadares et al., 1999), and an average creatinine 
output of 28 mg/kg of BW as estimated by Whittet (2004) was assumed. Similar creatinine 
outputs have been reported (25 to 30 mg/kg of BW daily) (McCarthy et al., 1983; Jones et al., 
1990). In order to estimate the relative differences in MCP production, the ratio of urinary PD 
(allantoin and uric acid) to creatinine was used (Shingfield and Offer, 1998), and the supply of 
MCP was estimated based on estimates of urinary excretion of PD according to the method of 
Chen et al. (1990) and Janicek et al. (2008). 
 
Ruminal Fermentation Characteristics  
 
Ruminal fluid samples were obtained using a Geishauser probe at 0, 3, and 6 h after the 
morning feeding on d 18 and 19 in each period. The fluid was collected with a solid, tube-like 
probe with rows of small holes on the end (Geishauser, 1993). The first 100 mL of ruminal fluid 
was discharged to avoid contamination from saliva, and then 10 mL was collected for analysis. 
The pH of the ruminal fluid was measured within 5 min of collecting the samples using a 
portable pH meter (Oakton pH 6; Oakton Instruments, Vernon Hills, IL). Five milliliters of the 
ruminal fluid were mixed with 1 mL of 1% sulfuric acid and stored frozen (−40°C) for ammonia-
N (NH3-N) analysis. Concentration of NH3-N in the ruminal contents was determined as 
described by Rhine et al. (1998), using a plate reader (MRXe; Dynex Technologies Inc., 




metaphosphoric acid, and then stored at −40°C for VFA content determination. Ruminal VFA 
were separated and quantified using a GLC (model 6890 series II; Hewlett-Packard Co., 
Avondale, PA) with a capillary column (30 m × 0.32-mm i.d., 1-μm phase thickness, Zebron ZB-
FAAP; Phenomenex Inc., Torrance, CA) and flame-ionization detection. The oven temperature 
was held at 170°C for 4 min, increased to 185°C at a rate of 5°C/min, then increased by 3°C/min 
to 220°C, and held at this temperature for 1 min. The injector and the detector temperatures were 




All data were analyzed as a 4 × 4 replicated Latin square with a factorial arrangement of 
treatments using the Proc Mixed procedure of SAS (version 9.4; SAS Institute Inc., Cary, NC). 
Data for intake, milk production, and energy partitioning were analyzed with a model that 
accounted for effects of square, MP difference (MPD vs. MPA), supplementation of NALM 
(−NALM vs. +NALM), day nested within period, and the interaction between MP, NALM, and 
day as fixed effects and cow within square and period within square as random effects with day 
included as a repeated measure. Data for ruminal pH, VFA, and NH3-N were analyzed using the 
model described above except that time after feeding was included as the repeated option. For 
each variable analyzed, 3 covariance structures (compound symmetry, autoregressive order 1, 
and unstructured covariance) were evaluated. The covariance structure that resulted in the lowest 
values for the Akaike information criterion and the Schwartz Bayesian criterion was used (Littell 




Residual errors were used to test main effects and interactions. Differences were considered 
significant at P ≤ 0.05, and trends were discussed at 0.05 < P ≤ 0.10. 
 
RESULTS AND DISCUSSION 
 
To the best of our knowledge, this is the first time that the effects of supplementing NALM 
in lactation dairy diets have been described. The lack of data in the literature regarding NALM 
led us to indirectly compare our results with data reported for HMBi as well as traditional 
polymer-protected Met (RPMet) products. 
 A continuous culture study estimated ruminal undegradability of N-acetyl-DL-Met at 67% 
(Windschitl and Stern, 1988). Monogastric data involving young pigs supplemented with NALM 
revealed that no NALM was present in either portal or vena caval plasma at any sampling time 
(Daabees et al., 1984), which indicates hydrolysis of NALM to Met in the intestinal lumen and 
mucosal cells. The research reported in this paper represents initial attempts to investigate 
lactational performance and ruminal fermentation profiles of dairy cows fed with NALM as an 
alternative RPMet source.  
 
Characteristics of Diet Composition and Treatment 
 
Ingredients and chemical composition of experimental diets are presented in Table 1-1. The 
MPA diet provided adequate MP, whereas the MPD diet was 6% MP-deficient (-181 to -190 
g/d). The MPD diet was formulated to contain less MP compared to the MPA diet by reducing 




deficiency was chosen for the MPD based on the result from Giallongo et al. (2016) who fed an 
MP-deficient diet (5-10%) supplemented with RPMet. All diets supplied NEL in excess of 
requirement (NRC, 2001). The MPA diet met or exceeded the MP, RDP, and RUP requirements, 
while the MPD diet was deficient for MP, RDP, and RUP as expected. 
The NRC (2001) model suggests that Lys and Met concentrations in MP for optimal milk 
protein production are 7.2 and 2.4%, respectively. These concentrations are difficult to achieve 
without feeding very high dietary concentrations of protein. Therefore, it is recommended that 
the first step in balancing diets for Lys and Met is to maintain a Lys:Met in MP of 3.0 with more 
practical concentrations of Lys and Met in MP being 6.6 and 2.2%, respectively (Schwab et al., 
2005). In this study, supplementing NALM (assuming 67% rumen undegradability) substantially 
improved Met status, as indicated by the reduction of the predicted (NRC, 2001) digestible Lys-
to-digestible Met ratio in MP from 3.5 to 2.7 (Table 1-1). The digestible Lys-to-digestible Met 
ratio for maximum milk and milk protein yield have traditionally been reported as a 3.00:1 
(NRC, 2001, Whitehouse et al., 2009), but optimal ratios as low as 2.69:1 were reported by Van 
Amburgh et al. (2015) when using the CNCPS model after calculating the optimum efficiency of 
utilization of Lys and Met using data derived by Lapierre et al. (2007) and from a meta-analysis 
of 40 published papers (Doepel et al., 2004). 
 
Feed Intake, Productive Performance, and Net Energy Utilization 
 
Intake of DM did not differ among dietary treatments, averaging 25.3 kg/d (Table 1-2). The 
MPD and the MPA diet with supplementation of NALM increased CP intake with a greater 




supplementation of polymer-coated RPMet and HMBi on feed intake and productive 
performance in the literature have been quite variable. Kung and Rode (1996) found that rumen-
protected AA supplementation did not improve DMI, which corresponds to the findings of other 
studies performed by Leonardi et al. (2003) and Chen et al. (2011). A limited number of studies 
have shown an increase in DMI with RPMet supplementation (Broderick et al., 2009; Zanton et 
al., 2014), while Ordway et al. (2009) and Zanton et al. (2014) reported decreases in DMI. 
Supplementation of HMBi has also increased DMI (Osorio et al., 2014) because of the potential 
stimulatory effect of HMBi on cellulolytic bacteria and the subsequent increase in passage rate 
and DMI (Lee et al., 2015). On the other hand, Lee et al. (2012b) assessed supplementation of 
RPMet products to MP-deficient diets, as was explored in the current study and reported that 
MP-deficient diets below 15% of the NRC requirements decreased DMI. However, the authors 
observed that a treatment supplemented with a combination of 3 rumen-protected AA consisted 
of Lys (100 g/cow), Met (30 g/cow), and His (50 g/cow) increased DMI (Lee et al., 2012b). An 
additional study by the same group (Lee et al., 2015) found that supplementation with rumen-
protected Lys and RPMet in MP-deficient diets (-256 to -305 MP g/d) did not affect DMI. In the 
current study, stage of lactation may have interfered with a potential effect of NALM on DMI 
under the MPA diet, because peak DMI typically tends to lag behind peak milk in early to mid-
lactating cows that consume feed in order to meet energy needs. 
Feeding the MPA diet increased milk yield by 2.2 kg/d relative to the MPD diet, resulting in 
more efficient feed utilization for milk production (1.64 vs. 1.57; Table 1-2). Milk yield was not 
affected by NALM supplementation, while yields of 3.5% FCM and ECM increased or tended to 
increase (P = 0.06) with NALM addition. Noftsger et al. (2005) reported no difference in milk 




Sylvester (2005) showed an increase in milk yield (2.9 kg/d) to cows supplemented with HMBi 
at 0.15% DM. The observed production responses to supplementation of RPMet in cows fed 
low-protein diets (i.e., MP-deficient diets) have been, in most cases, minimal and/or inconsistent 
(Arriola Apelo et al., 2014a; Sinclair et al., 2014). No negative effect on milk yield was detected 
by feeding a low CP diet (15%) alone or in combination with RPMet supplementation (Arriola 
Apelo et al., 2014b). In the current study, a 6% MP-deficient diet decreased milk yield, while 
previous research with MP-deficient diets (5-10% below MP requirement) have maintained milk 
yield (Lee et al., 2015; Giallongo et al., 2016). In the present study, there was no improvement in 
milk yield in response to NALM supplementation in both of the MPD and the MPA diet, thus 
indicating that NALM was not utilized for milk production. Alternatively, NALM 
supplementation increased yields of 3.5% FCM and ECM, suggesting a potential role on fatty 
acid synthesis and delivery to the mammary gland possibly through a methyl donation 
mechanism in the liver, which will be discussed later in this paper. 
There was a tendency toward MP × NALM interaction on milk fat concentration (P = 0.10), 
because NALM supplementation increased milk fat concentration under the MPA, but not the 
MPD diet (Table 1-2). However, milk true protein concentration was similar across the diets. 
Ordway et al. (2009) showed that HMBi did not increase milk fat concentration, but increased 
milk protein concentration in comparison to the control diet. In contrast, milk fat concentration 
increased with HMBi supplementation (Dalbach et al., 2011; Osorio et al., 2013). Supplementing 
RPMet typically results in an increase in milk protein percentage (Rulquin and Delaby, 1997; 
Samuelson et al., 2001; Lara et al., 2006), but one study (Benefield et al., 2009) reported a 
negative impact on milk protein concentration. It has been well established that Met acts as a 




primary methyl carrier during bovine hepatic methyl metabolism is S-adenosyl-Met (SAM). It 
works to donate methyl groups for the generation of phosphatidylethanolamine, acting as 
phospholipids for cell membranes in the packaging of very low-density lipoprotein (VLDL; 
Purohit et al., 2007). Once packaged, the VLDL consist of triglycerides, apolipoproteins B and 
E, phospholipids, and cholesterol, and consequently Met plays a vital role in both the 
development of apolipoproteins and phospholipids. The VLDL are then exported from the liver 
to the mammary gland for milk fat synthesis (Figure 1-1). Thus, as a potential mode of action, 
NALM after its digestion and absorption may have been involved in hepatic Met metabolism 
pertaining to fatty acid trafficking, leading to the increased milk fat production in early to mid-
lactation observed in the current study. 
It has been reported that aminoacylase I is present in multiple mammalian organs (i.e., small 
intestine, liver, and kidney; Giardina et al., 1997). The bovine liver contains the enzyme, α-N-
acylamino acid hydrolase which is capable of hydrolyzing α-N-acylated AA to yield acetate and 
the corresponding AA (Gade and Brown, 1981). However, it is unclear how cows utilize the 
NALM into conversion of milk fat, once NALM was hydrolyzed by aminoacylase I and 
absorbed in the small intestine as acetate and Met (Baxter et al., 2002) as was illustrated in the 
Figure 1-1.  
Feeding the MPA diet increased milk fat yield compared with the MPD diet, and 
supplementing NALM further increased milk fat yield regardless of MP level (Table 1-2). 
Although feeding the MPA diet increased milk protein yield compared with the MPD diet, 
NALM supplementation did not influence milk protein yield. Noftsger et al. (2005) and St-Pierre 
and Sylvester (2005) demonstrated an increase in milk protein yield with HMBi 




on milk protein vs. milk fat yield (Lara et al., 2006; Rulquin et al., 2006; Ordway et al., 2009). 
This is most likely due to Met being the first-limiting essential AA in lactation dairy diets, and 
consequently supplementation of HMBi or polymer-coated RPMet is first partitioned to improve 
milk protein yield in dairy cows. Contradictory effects have been reported (Phipps et al., 2008 
and Ordway et al., 2009) for HMBi on increased milk fat yield. Patton (2010) performed a meta-
analysis on 35 studies evaluating production performance in lactating dairy cows supplemented 
with various RPMet products to dairy diets and found increased production of true milk protein 
both as a percentage (0.07%) and yield (27 g/d). However, NALM supplementation did not 
increase milk protein yield, and thus NALM may have been used as a source of Met in methyl 
donation toward VLDL production as previously discussed. Further research is needed to 
determine the actual contribution of Met in NALM for VLDL formation and its impacts on milk 
production parameters.    
For the diets supplemented with NALM, the increased milk fat concentration and no change 
in DMI resulted in a tendency toward MP × NALM interaction on 3.5% FCM yield/DMI and 
ECM yield/DMI (P = 0.06; Table 1-2). A 12-wk study performed by Chen et al. (2011) showed 
that supplementing HMBi to lactating cows averaging 143 DIM increased ECM yield/DMI. Feed 
efficiency is a reasonable indicator evaluated on dairy farms, as it helps measure the relative 
ability of cows to convert feed nutrients into milk or milk components. The increased feed 
efficiencies observed in the current study suggest that NALM supplementation would be 
economically favorable in early to mid-lactating cows, but only when fed a diet adequate in MP 
concentration. However, caution should be exercised to extrapolate these benefits of NALM in 
the current study due to the short length of data collection and, therefore, further investigation is 




No changes were seen in either BW gain or net energy utilization with supplementation of 
NALM in the diets (Table 1-2). However, feeding the MPA diet increased milk yield relative to 
the MPD diet, leading to an increased net energy utilization for milk. Research on RPMet 
supplementation on BW gain in ruminants is scarce, but some studies have reported increases in 
BW gain upon RPMet supplementation (Deetz et al., 1985; Oke et al., 1986). Methionine is a 
limiting AA in protein synthesis for growing cattle (Richardson et al., 1978), and therefore an 
increase in available Met can support protein deposition in the body (Loest et al., 2002). The role 
of Met in the formation of phospholipids through conversion of Met to SAM will also support fat 
deposition in growing cattle (Obeid et al., 2009). In addition, acetate, a component of NALM, is 
also recognized for its role as a lipogenic precursor (Bauman and Griinari, 2001). No effect on 
BW gain due to NALM supplementation suggests that energy was partitioned for milk fat 
production rather than BW gain in early to mid-lactation in the present study. 
 
Plasma AA Profiles 
 
Among EAA, feeding the MPA diet increased plasma concentrations of Ile and Leu 
compared with the MPD diet, but supplementing NALM decreased those AA only under the 
MPA diet, resulting in an interaction between MP and NALM (Table 1-3). Supplementing 
NALM decreased plasma concentration of Val under the MPA but not the MPD diet, leading to a 
MP × NALM interaction. In contrast, Noftsger et al. (2005) did not find any difference in Val 
concentration when cows were supplemented with HMB, HMBi, or DL-Met. Similarly, St-Pierre 
et al. (2005) supplemented a control diet with HMB, HMBi, or a combination of HMB and 




Plasma concentration of Met increased under the MPD but not MPA, leading to an MP × NALM 
interaction. The no effect of NALM supplementation on plasma Met concentration in the MPA 
diet observed in this study was unexpected, and its mechanism is difficult to explain. The liver 
plays a central role in Met metabolism (Finkelstein, 1990); approximately 50% of Met 
metabolism and up to 85% of all methylation reactions occur in the mammalian liver (Mato et 
al., 2002). Hepatic gene regulation serves as an important regulatory point for controlling Met 
metabolism (Finkelstein, 2003; Mato et al., 2008). However, effects of RPMet supplementation 
on genes for Met metabolism in bovine hepatocytes in vivo has not been clearly understood in 
lactating dairy cattle. Zhang et al. (2016) demonstrated decreased mRNA expression for genes 
that catalyze regeneration of Met and showed the decreased need for cellular regeneration of Met 
with increasing Met concentrations from 2-hydroxy-4-(methylthio)-butanoic acid (HMB) and 
DL-Met on primary bovine hepatocytes. The authors described that increased Met supply from 
HMB and DL-Met in primary bovine hepatocytes was not directed at increased glucose 
synthesis, probably due to other metabolic priorities for Met (Zhang et al., 2016). Likewise, in 
the current study it is speculated that increased Met supply from NALM supplementation in the 
MPA diet may have been prioritized in the bovine hepatocyte to the primary methyl donor SAM, 
allowing SAM to be used for increased VLDL synthesis and exportation to the mammary gland 
for milk fat synthesis (Figure 1-1). 
 
Ruminal Fermentation Characteristics 
 
Ruminal pH decreased in the MPD relative to the MPA diet (6.24 vs. 6.37; Table 1-4), but 




treatments were at least above 6.2, so even the effect of MP difference on overall microbial 
physiology may have been minor. Concentration of VFA and their compositions were in general 
not affected by MP level as well as NALM supplementation. Similarly, Noftsger et al. (2005) 
and Lee et al. (2015) reported no effects of RPMet supplementation on ruminal pH and VFA 
production. Concentration of NH3-N also did not differ across the dietary treatments, while MCP 
yield increased due to feeding the MPA diet compared with the MPD diet, but NALM did not 
affect MCP yield regardless of MP level (Table 1-4). Supplementation of RPMet traditionally 
has not had an impact on microbial production, with the exception of Met analogues such as 
HMBi because of its partial ruminal degradation and potential stimulatory effects on MCP 
synthesis (Robert et al., 2001). Similarly, Lee et al. (2015) reported increased MCP yield with 
polymer-coated RPMet supplementation. Although NALM is partially degraded in the rumen 
(approximately 33%, Figure 1-1), the degraded fraction of the NALM would not contribute to 
MCP synthesis under the experimental condition of our study. Further research is needed to 
understand the mode of action of NALM on ruminal metabolism, particularly how the 




The current study investigated the production responses and ruminal fermentation profiles of 
early to mid-lactating dairy cows supplemented without or with a developmental NALM product 
in the MPD or the MPA diet. The NALM supplementation did not affect DMI, milk yield, and 
milk protein yield or alter ruminal fermentation characteristics in either the MPD or the MPA 




metabolic priorities for Met. However, supplementation of NALM regardless of MP difference 
increased both 3.5% FCM and ECM yields coupled with increased milk fat concentration which 
was more impactful in the MPA diet, leading to better feed efficiencies with the MPA diet. Thus, 
supplementing NALM, particularly in the MPA diet, in early to mid-lactation can be a good 
approach to formulate an optimal dairy feeding program for improving feed efficiency. Yet, the 
potential effects of NALM on intermediary metabolism between the gastrointestinal tract, the 
liver, and the mammary gland needs to be explored to understand the metabolic impacts of 
NALM on lactational and physiological parameters of dairy cows. Overall, the results in the 
current study suggest that NALM exerted minor influence on ruminal metabolism, but increased 
milk fat concentration possibly due to accelerated fatty acid delivery to the mammary gland, 
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Table 1-1. Ingredient and chemical composition of the experimental diets without or with N-
acetyl-L-Met (NALM) at 2 different levels of MP fed to lactating Holstein dairy cows (n = 4) 
Item 
Experimental diet1 
MPD  MPA 
−NALM +NALM  −NALM +NALM 
Ingredient, % of DM      
Alfalfa hay 27.0 27.0  25.8 25.7 
Wheat straw 2.49 2.49  2.38 2.38 
Corn silage 32.5 32.5  31.0 31.0 
Corn grain (steam-flaked) 11.6 11.6  11.1 11.1 
Corn grain (high-moisture) 6.17 6.17  5.90 5.89 
Cottonseed, whole 4.88 4.87  4.66 4.65 
Canola meal 3.50 3.50  5.68 5.68 
Soybean meal 3.25 3.24  5.27 5.27 
Beet pulp, shreds 4.93 4.92  4.71 4.70 
NALM2 − 0.13  − 0.13 
Sodium bicarbonate 1.08 1.08  1.03 1.03 
Vitamin and mineral mix3 2.54 2.54  2.43 2.42 
Chemical composition, % of DM      
DM, % 60.9 ± 0.53 60.7 ± 0.32  61.0 ± 0.72 62.0 ± 1.50 
OM 92.1 ± 0.60 91.6 ± 0.71  92.0 ± 0.84 92.0 ± 0.66 
CP  15.2 ± 0.14 15.4 ± 0.21  16.1 ± 0.49 16.8 ± 0.35 




RUP4  5.68 5.92  6.23 6.50 
NDF 37.8 ± 1.37 37.0 ± 1.88  37.4 ± 1.06 38.2 ± 0.65 
ADF 23.7 ± 0.85 23.4 ± 0.88  23.4 ± 0.84 24.0 ± 0.74 
Starch 17.5 ± 0.57 19.0 ± 1.91  18.9 ± 0.99 16.6 ± 0.07 
Ether extract 1.66 ± 0.61 1.91 ± 0.86  1.86 ± 0.39 1.68 ± 0.73 
NFC5 37.4 ± 0.14 37.0 ± 0.21  36.7 ± 0.49 35.4 ± 0.35 
NEL,
4 Mcal/kg 1.67 1.67  1.68 1.68 
Protein supply,6 g/d      
RDP supply 2,342 2,443  2,494 2,616 
RDP balance -128 -27  24 146 
RUP supply 1,397 1,499  1,595 1,651 
RUP balance -173 -71  25 81 
MP supply 2,781 2,791  3,049 3,059 
MP requirements 2,972 2,972  2,998 3,004 
MP balance -190 -181  50 55 
Lys and Met balance,7 g/d      
dLys requirement 184 184  201 202 
dLys supplied by the diet 191 191  209 209 
Lys balance 7.0 7.0  8.0 7.0 
dMet requirement 61 61  67 67 
dMet supplied by the diet 55 55  60 60 













dLys:dMet8 3.47 2.71  3.48 2.76 
 
1MPD−NALM = diet deficient in MP (MPD) without NALM; MPD+NALM = MPD with 
NALM; MPA−NALM = diet adequate in MP (MPA) without NALM; and MPA+NALM = MPA 
with NALM. 
2A developmental NALM product (CJ CheilJedang, Seoul, Korea) was a source of rumen-
protected Met, and it contained 78.0% Met. 
3Formulated to contain (per kg DM): 226.7 mg of Se (from sodium selenite), 9278.7 mg of Cu 
(from copper amino acid complex), 40,537.4 mg of Zn (from zinc amino acid complex), 
38,653.4 mg of Mn (from manganese amino acid complex), 552.6 mg of Co (from cobalt 
carbonate), 1,234,585.2 IU of vitamin A, 152,808.1 IU of vitamin D, 3,815.1 IU of vitamin E, 
and 295 mg of Rumensin (Elanco Animal Health, Greenfield, IN). 
4Based on tabular value (NRC, 2001).  
5NFC = 100 – CP – NDF – ether extract – ash. 
6All values were estimated using NRC (2001) based on actual DMI, milk yield, milk 
composition, and BW of the cows throughout the trial. 
7Digestible Lys (dLys) and digestible Met (dMet) supply from the diets were estimated using 
NRC (2001); supply of dMet from Met derivative was estimated with Met concentration and 
absorption (67%) data provided the manufacturer. Requirements of dLys and dMet were 
calculated as 6.6 and 2.2% (respectively) of MP requirements. 






Table 1-2. Intake, milk production, feed efficiency, and net energy utilization of lactating Holstein dairy cows 




Significance of effect2 MPD  MPA 
−NALM +NALM  −NALM +NALM MP NALM INT 
DM intake, kg/d 24.6 25.6  25.4 25.4 1.34 0.67 0.46 0.44 
Yield, kg/d          
Milk 39.3 39.7  41.3 42.0 2.60 < 0.01 0.48 0.81 
3.5% FCM3 39.0 39.9  40.4 43.4 2.65 0.02 0.05 0.29 
ECM4 38.7 39.7  40.2 42.9 2.51 0.02 0.06 0.35 
Milk composition, %          
Fat 3.44 3.52  3.34 3.70 0.121 0.65 0.02 0.10 
True protein 2.77 2.82  2.78 2.83 0.083 0.82 0.21 0.92 
Lactose 4.84 4.87  4.88 4.85 0.049 0.65 0.97 0.26 
Milk component yield, 
kg/d 
         
Fat 1.36 1.41  1.39 1.56 0.100 0.05 0.03 0.20 
True protein 1.08 1.11  1.14 1.18 0.064 0.04 0.24 0.75 
Lactose 1.91 1.93  2.02 2.04 0.128 < 0.01 0.53 0.95 
Feed efficiency          
Milk yield/DMI 1.59 1.55  1.61 1.66 0.075 0.03 0.83 0.10 




ECM yield/DMI 1.57b 1.55b  1.57b 1.70a 0.073 0.05 0.11 0.06 
BW          
Initial, kg 704 698  702 704 21.7 0.56 0.66 0.26 
Mean, kg 705 705  710 713 21.2 0.03 0.74 0.60 
Gain, kg/d 0.06 0.30  0.40 0.40 0.345 0.24 0.51 0.51 
Net energy utilization, 
Mcal/d 
         
Maintenance 10.9 10.9  11.0 11.0 0.25 0.03 0.73 0.57 
BW gain 0.24 1.16  1.55 1.55 1.322 0.24 0.51 0.51 
Milk 26.2 26.1  26.8 28.5 1.67 0.03 0.20 0.16 
Total5 37.4 38.2  39.3 41.1 2.19 0.03 0.21 0.65 
NEL, Mcal/kg DMI
 1.49 1.55  1.55 1.60 0.074 0.13 0.18 0.94 
 
a-dMeans within a row with different superscripts differ (P < 0.05). 
1MPD−NALM = diet deficient in MP (MPD) without NALM; MPD+NALM = MPD with NALM; 
MPA−NALM = diet adequate in MP (MPA) without NALM; and MPA+NALM = MPA with NALM. 
2MP = level of MP in the diet (MPD vs. MPA); NALM = supplementation of NALM (−NALM vs. 
+NALM); and INT = interaction between MP and NALM. 
33.5% FCM = [0.4324 × milk yield (kg/d)] + [16.216 × fat yield (kg/d)]. 
4ECM = 0.327 × milk yield (kg/d) + 12.95 × fat yield (kg/d) + 7.2 × protein yield (kg/d). 





Table 1-3. Plasma AA concentrations (µmol/L) of lactating Holstein dairy cows supplemented 




Significance of effect2 MPD  MPA 
−NALM +NALM  −NALM +NALM MP NALM INT 
His 10.1 11.6  10.2 9.7 5.60 0.51 0.70 0.48 
Ile 85.3b 90.5b  102a 91.9b 9.39 < 0.01 0.35 < 0.01 
Leu 119b 122b  144a 123b 12.5 < 0.01 0.02 < 0.01 
Lys 61.2 65.8  68.0 65.0 17.61 0.40 0.83 0.29 
Met 18.0b 19.6a  18.3ab 17.4b 0.85 0.06 0.49 0.01 
Phe 71.3b 73.2ab  76.4a 70.6b 5.23 0.44 0.24 0.02 
Thr 31.6 33.1  32.1 29.0 7.38 0.25 0.59 0.13 
Val 248b 266b  283a 241b 23.3 0.74 0.43 0.05 
Ala 196b 195b  200a 181b 14.3 0.36 0.04 0.07 
Asp 37.9 49.8  46.9 38.1 9.48 0.77 0.75 0.03 
Glu 24.8 23.3  24.2 22.6 2.50 0.47 0.09 0.99 
Gly 198a 198a  188ab 168c 20.9 < 0.01 0.07 0.07 
Pro 78.0ab 75.3bc  80.8a 70.3c 6.68 0.54 < 0.01 0.04 
Tyr 138 166  168 159 42.2 0.35 0.44 0.13 
EAA3  645b 682ab  720a 648b 21.6 0.34 0.42 0.01 
NEAA4 793 707  694 638 64.3 0.19 0.27 0.82 
 




1MPD−NALM = diet deficient in MP (MPD) without NALM; MPD+NALM = MPD with NALM; 
MPA−NALM = diet adequate in MP (MPA) without NALM; and MPA+NALM = MPA with NALM. 
2MP = level of MP in the diet (MPD vs. MPA); NALM = supplementation of NALM (−NALM 
vs. +NALM); and INT = interaction between MP and NALM. 
3Essential amino acid analyzed.  




















Table 1-4. Ruminal fermentation characteristics of lactating Holstein dairy cows supplemented without 




Significance of effect2 MPD  MPA 
−NALM +NALM  −NALM +NALM MP NALM INT 
Ruminal pH 6.26 6.21  6.35 6.39 0.101 0.03 0.95 0.48 
Total VFA, mM 146 154  147 144 6.6 0.53 0.68 0.39 
Individual VFA, 
mol/100 mol 
         
Acetate (A)  62.4 62.0  62.0 62.4 3.79 0.96 0.93 0.26 
Propionate (P) 23.3 23.7  23.2 23.3 2.99 0.60 0.65 0.80 
Butyrate 10.7 10.6  11.0 10.7 0.97 0.49 0.47 0.70 
Valerate 1.57 1.66  1.47 1.62 0.403 0.30 0.09 0.61 
Isobutyrate 0.79 0.89  0.95 0.87 0.128 0.27 0.88 0.14 
Isovalerate 1.27b 1.27b  1.41a 1.20b 0.179 0.52 0.04 0.06 




9.34 9.05  9.28 9.82 1.425 0.70 0.89 0.65 
MCP,4 g/d 2,540 2,649  2,954 2,837 237.7 < 0.01 0.96 0.16 
 
a,bMeans within a row with different superscripts differ (P < 0.05). 
1MPD−NALM = diet deficient in MP (MPD) without NALM; MPD+NALM = MPD with NALM; 




2MP = level of MP in the diet (MPD vs. MPA); NALM = supplementation of NALM (−NALM vs. 
+NALM); and INT = interaction between MP and NALM. 
3Ammonia-N. 
4Microbial protein production (g/d) = ({[urinary total purine derivatives (allantoin + uric acid) − (0.385 × 


















Figure 1-1. Proposed mechanism of N-acetyl-L-Met (NALM) on its potential effects on milk fat and milk production. SAM = S-





Effects of supplementing three different forms of rumen-protected lysine on 




The present study investigated lactational performance of dairy cows when 
supplemented with N-acetyl-L-Lys (εNALL), N, -acetyl-L-Lys (diNALL), or 
AjiPro-L (AP) as a source of rumen-protected Lys (RPLys) to a control diet. Control 
cows (CL) were provided the basal diet formulated to contain 15.3% CP and supply 
adequate MP (+ 10 g/d balance). Forty lactating Holstein dairy cows (151 ± 78.0 days-in-
milk, on average) were assigned to treatments (n = 10) by parity and days-in-milk, and 
the experiment was performed in a randomized complete block design. Cows were fed 
the same CL diet for a 2-wk adaptation period. Cows were then randomly assigned within 
blocks to 1 of the 4 experimental diets and fed assigned diets throughout the remaining 8 
wk of the trial (entire study duration was 70 d). Developmental NALL, diNALL, and the 
commercial RPLys product AP were supplemented to the CL diet at 51.5, 63, and 100 
g/cow/d to provide 20 g/d of digestible Lys, respectively. Feeding the diNALL and the 
AP diets decreased DMI. Milk yield was not altered by RPLys supplementation. Milk 
composition (%) and milk component yields were not affected by RPLys 




the diNALL diet in comparison to the CL diet. Body weight change was not affected by 
RPLys supplementation. The diNALL diet shifted net energy partitioning (% energy 
intake) toward milk production. Dietary treatments had similar plasma AA, N utilization, 
and rumen NH3-N concentrations. Overall, results in the current study suggest that 
diNALL and AP decreased DMI leading to improved milk production efficiency. 
However, based on the current findings, the potential effects of RPLys on DMI regulation 
warrant further investigation as stage of lactation and physiological changes occurring 
through stage of lactation may have alter DMI. 





Lysine is commonly considered the first limiting essential AA (EAA) in dairy cows 
fed a corn-based ration or rations that include corn by-products, such as dried distillers 
grains with solubles (Schingoethe et al., 2009). Lysine’s main biological role in dairy 
cattle is to promote protein synthesis. Lysine may be used for weight gain in growing 
dairy cattle, milk protein production in lactating dairy cows, incorporation into 
mammalian tissues for structural integrity, or serve as a carbon backbone for carnitine 
synthesis (NRC, 2001; Vaz and Wanders, 2002). However, for Lys products to exert their 
biological effects in dairy cows, they must be able to avoid microbial degradation in the 




An effective method to increase post-ruminal Lys supply and improve post-ruminal 
Lys absorptive efficiency is to feed rumen-protected Lys (RPLys). Inconsistent post-
ruminal polymer degradation and high production costs have limited the development of 
RPLys products (Swanepoel et al., 2010). However, since the early 1990s rumen stable 
AA matrixes have been developed and numerous RPLys products have become available 
for commercial use in animal agriculture (Robinson, 2009b). Available commercial 
RPLys products use encapsulation, matrix technology, or a combination of both to protect 
a Lys core from ruminal degradation (Ji et al., 2016). These RPLys products are often 
coated by a series of lipid or fatty acid calcium-based salts (Ji et al., 2016). Wu and Papas 
(1997) found that RPLys coating protection efficacy in the rumen depends on coating 
composition, pellet surface smoothness, inner core pellet strength, and pellet solubility 
and size. Recently, the production of Lys derivatives, a new form of RPLys may serve as 
an alternative to physically protected lipid RPLys products. 
The N-acetyl-L-Lys (NALL) is a Lys derivative produced via protection of the L-Lys 
α-amino (Nα, ε-acetyl-L-Lys; diNALL) or ε-amino (Nε-acetyl-L-Lys; εNALL) group 
with an N-acetyl group. The biological availability of N-substituted Lys products has 
previously been described (Finot et al., 1978). The biological availability for diNALL 
and εNALL is 0 and 50% in the rat, respectively (Neuberger and Sanger, 1943; Bjarnason 
and Carpenter, 1969). According to Finot et al. (1978) the Lys derivatives which are 
partially utilized as Lys sources in rats are Nε-formyl-L-Lys and εNALL. They belong to 
the group of Nε-acyl-Lys and are negligibly hydrolyzed by homogenates of the intestinal 




and Benoiton (1963) and Leclerc and Benoiton (1968) found that it is the renal ε-Lys 
acylase which is responsible for Nε-formyl-L-Lys and εNALL hydrolysis. It is 
anticipated that εNALL will be biologically available in lactating dairy cows, however, 
there is no research reported on the effects of supplementing NALL in lactation diets on 
production and ruminal fermentation in dairy cows.  
 The objective of the present study was to investigate lactational performance and 
nutrient utilization by mid to late lactating dairy cows supplemented with 3 different 
forms of RPLys. We hypothesized that supplementing RPLys to mid to late lactation 
dairy cows would increase post-ruminal Lys supply and increase milk protein synthesis 
and milk yield. 
 
MATERIALS AND METHODS 
 
The dairy cows used in the present study were cared for according to the Live Animal 
Use in Research Guidelines of the Institutional Animal Care and Use Committee at Utah 
State University. The study was conducted at the Caine Dairy Research Center 
(Wellsville, UT), Utah State University from July to September, 2017. 
 
Cows, Experimental Design, and Diets 
 
Forty multiparous lactating Holstein dairy cows were used during the trial. Cows 




151 ± 78.0 DIM and producing 39.6 ± 6.89 kg milk/d. The experiment was performed as 
a randomized complete block design. Cows were grouped into 10 blocks of 4 cows by 
parity and DIM. Cows were fed the same control diet (CL) for a 2-wk adaptation period. 
Cows were then randomly assigned within blocks to 1 of the 4 experimental diets and fed 
assigned diets throughout the remaining 8 wk of the trial (entire study duration was 70 d). 
Experimental diets were based on alfalfa hay, corn silage, and dried distillers grains with 
solubles. Table 2-1 lists the chemical composition of the 4 dietary treatments. The control 
diet was formulated to contain 15.3% CP and supply adequate MP (+ 10 g/d balance).  
The dietary treatments fed in the study are as follows; 1) CL = normal CP (15.3%) 
without RPLys, 2) NALL = normal CP with NALL (51.5 g/d), 3) diNALL = normal 
CP with diNALL (63 g/d), and 4) AP = normal CP with AjiPro®-L (100 g/d).  
The developmental NALL products from CJ CheilJedang (Seoul, South Korea) were 
used as a supplemental source of RPLys in this study. N-acetyl-L-Lys and diNALL are 
protected from rumen degradation with an N-acetyl group attached to either the α- or the  
-amino group. The NALL and diNALL products were added at a rate of 51.5 and 63 
g/d, respectively. The rate was determined for lactating dairy cows based on 
manufacturer’s recommendation in order to supply 20 g of digestible Lys to the small 
intestine. The recommendation of required digestible Lys and Met were assumed as 6.6 
and 2.2% of the MP requirements, respectively (NRC, 2001). The RPLys products were 
top-dressed onto corresponding experimental diets at each a.m. feeding. Diets were 




vitamins, and minerals with an estimated intake of 25.0 kg/d to produce 36 kg/d of milk 
with 3.5% fat and 3.0% true protein (Table 2-1).  
Cows were housed individually in tie stalls fitted with rubber mattresses covered with 
straw, allowing free access to water. Cows were individually fed twice daily for ad 
libitum intake at a level of 110% expected daily intake with 60% of allotted feed fed at 
0800 h and 40% fed at 1500 h. Feed offered and refused were recorded daily, and feed 
samples were taken during each week of the trial to determine DMI. Cows were milked 
twice daily at 0600 and 1600 h, and milk production was recorded throughout the entire 
experiment.  
 
Energy Partitioning Calculations 
 
Energy partitioning was determined during sampling weeks using data of milk yield, 
milk composition, and BW of experimental animals. Cows were weighed for 2 
consecutive d after the a.m. milking and before the a.m. feeding at the end of weeks 2, 4, 
6, 8 and 10. These weights were used to calculate the mean BW of cows for each 
sampling week. Energy used for maintenance was calculated as BW0.75× 0.08 (NRC, 
2001). Energy of BW change was assumed to be 5.114 Mcal/kg of gain or 4.924 Mcal/kg 
of loss (NRC, 2001). Milk energy was calculated as (0.0929 × milk fat concentration) + 
(0.0563 × milk true protein concentration) + (0.0395 × milk lactose concentration) (NRC, 
2001). Estimated NEL value was calculated by total net energy utilization (maintenance, 





Feed and Milk Samplings and Analyses 
 
Samples of alfalfa hay, corn silage and dried distiller grains were taken weekly to 
determine DM, and diets were adjusted accordingly for change in forage DM 
concentration. Samples were ground to pass a 1-mm screen (standard model 4; Arthur H. 
Thomas Co., Swedesboro, NJ), and stored for chemical analysis. Samples of TMR and 
orts were collected from individual cows on d 3 and d 4, at the end of the adaptation 
period and sampling weeks (3 through 10) composited, dried at 60°C for 48 h, and 
ground as previously described. The DM concentrations of samples were used to 
calculate intakes of DM and nutrients. 
Analytical DM concentration of samples was determined by oven drying overnight at 
105°C, and OM was determined by ashing at 550°C for 5 h (AOAC, 2000; method 
942.05). Concentration of CP was determined using an automated N combustion analyzer 
(Elementar, Analysensysteme GmbH, Hanau, Germany; AOAC, 2000; method 968.06). 
Concentrations of NDF and ADF were sequentially determined using a fiber analyzer 
(200/220, ANKOM Technology, Macedon, NY) according to the methodology supplied 
by the company, which is based on the methods described by Van Soest et al. (1991). 
Sodium sulfite was used in the procedure for NDF determination and pre-treated with 
heat-stable amylase (Type XI-A from Bacillus subtilis; Sigma-Aldrich Corporation, St. 
Louis, MO). Ether extract was measured using a fat analyzer (XT20, ANKOM 




analyzed for starch by Dairyland Laboratories, Inc. (Arcadia, WI) according to Knudsen 
(1997).  
Milk was sampled for 2 consecutive d (d 3 and 4) during the a.m. and p.m. milkings 
each week. Individual milk samples were analyzed by the Rocky Mountain DHIA 
Laboratory (Logan, UT) for fat, true protein, lactose, and MUN. Milk composition was 
expressed on weighted milk yield of a.m. and p.m. samples. Milk fat and protein yields 
were calculated by multiplying milk yield from the respective day by fat and true protein 
concentration of the milk from an individual cow. 
 
Blood Samplings and Analyses 
 
Blood samples were collected immediately before the morning feeding and at 1400 h 
into 10-mL EDTA plasma vacuum tubes from the coccygeal artery or vein on d 6 and 7 
in each sampling week (4, 6, 8, and 10) and placed on ice. Blood samples were 
centrifuged at 2,300 × g for 20 min, and plasma was collected and stored at ‒40°C for 
subsequent AA analysis. The plasma samples were prepared for AA analysis using the 
EZ:faast GC-FID Free (Physiological) AA Analysis kit (Phenomenex Inc., Torrance, 
CA). Concentrations of plasma free AA were determined in accordance with the user 
manual provided with the kit. Extraction of free AA from the plasma consisted of a 
combination of solid-phase extraction, derivatization, and liquid/liquid extraction. The 
organic phase containing the AA in question were analyzed using a GC (model 5890, 




phase thickness, Zebron ZB-FAAP; Phenomenex Inc., Torrance, CA) and flame-
ionization detection. 
 
Ruminal Fermentation Characteristics  
 
Ruminal fluid samples were obtained using a Geishauser probe at 3 h after the 
morning feeding on d 5 and 6 of each sampling week (4, 6, 8, and 10). The fluid was 
collected with a solid, tube-like probe with rows of small holes on the end (Geishauser, 
1993). The first 100 mL of ruminal fluid was discharged to avoid contamination from 
saliva, and then 10 mL was collected for analysis. The pH of the ruminal fluid was 
measured within 5 min of collecting the samples using a portable pH meter (Oakton pH 
6; Oakton Instruments, Vernon Hills, IL). Five milliliters of the ruminal fluid were mixed 
with 1 mL of 1% sulfuric acid and stored frozen (−40°C) for ammonia-N (NH3-N) 
analysis. Concentration of NH3-N in the ruminal contents was determined as described by 
Rhine et al. (1998), using a plate reader (MRXe; Dynex Technologies Inc., Chantilly, 
VA). Another 5 mL of the ruminal fluid was collected and mixed with 1 mL of 25% 
metaphosphoric acid, and then stored at −40°C for VFA content determination. Ruminal 
VFA were separated and quantified using a GC (model 6890 series II; Hewlett-Packard 
Co.) with a capillary column (30 m × 0.32-mm i.d., 1-μm phase thickness, Zebron ZB-
FAAP; Phenomenex Inc., Torrance, CA) and flame-ionization detection. The oven 
temperature was held at 170°C for 4 min, increased to 185°C at a rate of 5°C/min, then 




the detector temperatures were 225 and 250°C, respectively, and the carrier gas was 




Statistical analyses of all data except BW change, N excretion, AA and VFA were 
conducted using the Proc Mixed procedure of SAS (version 9.4; SAS Institute Inc., Cary, 
NC) with a repeated measures model that included the covariate mean for each trait for 
each cow, plus block, treatment, week, and the interaction of treatment × week. A similar 
approach was used for BW change, N excretion, AA and VFA data, except the covariate 
was removed from the model. Overall, treatment differences were examined using least 
squares means with the lowest standard error. Week and block were included in the final 
statistical model for all analyses. The PDIFF option of SAS (version 9.4; SAS Institute 
Inc., Cary, NC) was used to test treatment differences among least squares means, and the 
SLICE option was used to analyze treatment differences among weekly treatment means. 
Differences were considered significant at P ≤ 0.05, and trends were discussed at 0.05 < 
P ≤ 0.10. 
 
RESULTS AND DISCUSSION 
 





Ingredients and chemical composition of experimental diets are presented in Table 2-
1. The CL diet had a CP content of 15.3%, which provided an adequate MP supply of 
2,910 g/d (+ 10 g/d balance), whereas the RPLys supplemented diets provided an MP 
supply of 2,930 g/d (+ 30 g/d balance) according to NRC (2001). Corn distillers grains 
were added to the CL diet at an inclusion rate of 21% of DM in order to achieve a Lys 
balance of – 20 g/d. High inclusion rates of corn distillers grains above 20% of DM have 
been shown to increase the amount of rumen biohydrogenation intermediates (Hippen et 
al., 2004) and may decrease milk fat concentration. Therefore, caution was taken to 
ensure that the NDF concentration in the diets remained near NRC (2001) 
recommendation of 25 to 33% of diet DM as total NDF. The RPLys supplemented diets 
maintained a Lys balance of – 1 g/d (0 g/d Lys balance targeted) by providing 20 g of 
metabolizable Lys to the diets based on manufacturers recommendation for each Lys 
treatment. All diets supplied NEL in excess of requirement (NRC, 2001).  
The concentrations of Lys and Met in MP was 6.6 and 2.2%, respectively. Digestible 
Lys and Met concentrations in MP (dLys:dMet) were maintained at 3.05:1 for RPLys 
supplemented diets and 2.73:1 for the CL diet. The dLys:dMet ratio for optimal milk and 
milk protein yield is reported in the NRC as 3.0:1 (NRC, 2001), but ratios as low as 
2.69:1 have been reported (Doepel et al., 2004; Van Amburgh et al., 2015). 
 





Feeding the diNALL and the AP diets reduced intake of DM compared to the CL diet 
(Table 2-2). Responses to supplementation of RPLys on feed intake in the literature are 
limited. Paz et al. (2014) reported that RPLys supplementation did not affect DMI in 
lactating dairy cows, which agrees with Blauwiekel et al. (1997) and Robinson et al. 
(2011). Swanepoel et al. (2010) found that supplementation of RPLys did not influence 
DMI in early lactating cows (77 ± 3.2 DIM); however, the mid lactation group (262 ± 
6.70 DIM) had a tendency (P = 0.09) toward lower DMI with RPLys supplementation. 
The mechanism by which RPLys reduces DMI in mid lactation cows is unknown, but the 
authors suggested that RPLys possibly affected animal metabolism, which reduced 
digestion in the lower digestive tract (Swanepoel et al., 2010).  
A variety of factors such as forage quality, TMR nutrient balance, feed delivery, 
feeding method, TMR palatability, ration DM content, environmental conditions, housing 
facilities, and managerial practices can impact DMI (Allen and Bradford, 2009), which 
might explain the lack of response seen with NALL supplementation. In the current 
study, stage of lactation and week of trial may have altered DMI in cows fed the diNALL 
and AP diets. This is because energy requirements decrease during mid lactation and 
control of feed intake by gut distension gradually diminishes, while control by hepatic 
oxidation increases (Allen and Bradford, 2009). Therefore, physiological changes 
occurring through stage of lactation and the physical and chemical characteristics (NDF 
concentration) of feeds beyond their nutrient composition can alter DMI (Allen and 




Supplementation of RPLys did not alter milk yield (Table 2-2). Milk, 3.5% FCM, and 
ECM yields were not affected by dietary treatments. Swanepoel et al. (2010) observed 
that dairy cows supplemented with RPLys at a rate of 41 g/cow/d did not affect milk 
yield in early lactation. Paz and Kononoff (2014) did not detect a difference in milk yield 
when RPLys was supplemented to diets with altering inclusion rates of low-fat dried 
distillers grains (15 vs. 30% of diet DM). Furthermore, cows supplemented with RPLys 
(37 g/cow/d) after peak lactation showed no improvement in milk yield (Bernard et al., 
2014). In contrast, Robinson et al. (2011) found a 2 kg increase in milk yield when 
RPLys was supplemented to deliver 15 to 21 g of MP Lys. In the present study, there was 
no improvement in milk yield in response to RPLys supplementation, thus indicating that 
RPLys was not utilized in the mammary gland of mid to late lactating dairy cows for milk 
production. The RPLys supplemental dosage rate, lack of a digestible Lys delivery to the 
small intestine for absorption, or reduced DMI may be responsible for the absence of 
production responses seen in the current study. 
Milk composition (%) and milk component yields (kg/d) were not affected by dietary 
treatments (Table 2-2). Swanepoel et al. (2010) reported reduced milk fat synthesis to 
feeding a RPLys product to high producing dairy cows. Třináctý et al. (2009) fed RPLys 
to lactating Holstein dairy cows (33.5 kg/d) and while milk protein concentration 
increased, milk fat concentration and yield declined. A review of literature by Robinson 
(2010) stated that RPLys supplementation generally results in minimal production 
responses, possibly due to an AA imbalance or poor AA delivery to the intestinal 




performance effects in lactating dairy cows can only be judged as negative (Robinson, 
2010). However, increased Lys supply appear important in early lactation when MCP 
synthesis is reduced because of lower DMI, to help drive milk and milk protein 
production (Robinson et al., 2011). Stage of lactation (mid to late) or lack of a digestible 
Lys deficiency in the diets supplemented with RPLys may be responsible for the absence 
of production responses seen in the current study. 
The diNALL diet reduced intake of DM and maintained milk yield resulting in better 
feed efficiency for milk production compared to the CL diet (1.54 vs. 1.33; Table 2-2). 
Wang et al. (2010) supplemented L-Lys-HCl at 0.50% DM to a control diet and detected 
increased milk yield with no increase in DMI, improving feed efficiency to 1.34 vs. 1.27 
for the control diet. As previously mentioned, the biological availability for diNALL and 
εNALL is 0 and 50% in the rat based on growth rates (Neuberger and Sanger, 1943). The 
improvement in feed efficiency for milk production with diNALL supplementation 
demonstrate that, unlike in the rat, diNALL may be biologically available in lactating 
dairy cows. Additionally, the increased feed efficiency observed in the current study 
suggest that diNALL supplementation would be favorable in mid to late lactating cows, 
but only when fed to a diet that has a digestible Lys deficit. Based on the current findings 
the biological availabilities of diNALL and εNALL in lactating dairy cows warrant 
further investigation. 
No changes were seen in either BW gain or net energy utilization with 
supplementation of RPLys in the diets (Table 2-2). However, feeding the diNALL diet 




for milk. No effect on BW gain due to diNALL supplementation suggests that energy 
was primarily partitioned toward milk production rather than BW gain in mid to late 
lactation in the current study. 
 
Plasma AA Profiles 
 
Plasma AA concentrations (EAA and NEAA) were not affected by RPLys 
supplementation (Table 2-3). The plasma Lys concentrations observed in the current 
study (Table 2-3) agree with Swanepoel et al. (2010), who did not detect a difference in 
plasma Lys concentrations of mid lactating dairy cows supplemented with RPLys at 41 
g/cow/d. Since, RPLys was supplemented to the CL diets, an increase in plasma Lys 
concentration was expected. However, because digestible Lys requirements were met, the 
absorbed Lys may have been used for biological functions other than milk production, 
converted to metabolites or not utilized. Lysine is an AA with a high fractional extraction 
rate by the mammary gland in ruminants (Manjarin et al., 2014). The primary metabolic 
fate of Lys in the mammary gland is for milk and milk protein synthesis. Mabjeesh et al. 
(2000) observed that the uptake of Lys in the mammary gland of dairy cows is greater 
than milk Lys output. The plasma Lys concentration along with changes in production 
parameters (i.e., milk yield) for the diNALL diet indicates that plasma Lys may have 
been utilized for improved milk yield. Since, plasma AA profiles were not altered by 
RPLys supplementation, further research is needed to determine the impact of Lys 





Utilization of N 
 
Intake of N in the current study followed DMI, meaning that cows fed the diNALL 
and the AP diets consumed less N than those fed the NALL and CL diets (Table 2-4). 
Supplementation of RPLys products do not often increase N intake because of either a 
lower dietary CP or MP concentration in basal diets associated with RPLys or a 
combination of RPAA supplementation (Leonardi et al., 2003; Broderick et al., 2009). 
Lee et al. (2015) supplemented a MP-deficient diet (MP balance of −281 g/d; CP of 
13.7% DM); with 100 g of RPLys/cow/d (estimated digestible Lys supply = 24 g/d) and 
reported no increase in N intake compared to the MP-deficient diet. Supplementation of 
RPLys had no effect on milk N excretion in the current study. Milk N efficiency is 
primarily driven by feed N intake (Huhtanen and Hristov, 2009). Although the N intake 
was reduced for the diNALL and the AP diets, no change in milk N excretion after 
supplementation of RPLys resulted in milk N:N intakes that were similar across all diets 
(0.32 on average). The N utilization efficiencies reported in the current study are similar 
to the average N efficiencies (25 to 35%) reported in the literature (Hristov et al., 2004). 
The lack of response in milk N to dietary treatments is related to DMI and milk yield 
seen in the current study. 
Concentrations of MUN and NH3-N were not affected by dietary treatments. Urea-N 
(milk, serum, and urine) in cattle is derived from excess NH3-N absorbed through the 




Wang et al., 2008). Wang et al. (2010) supplemented L-Lys-HCl at 0.50% of DM to a 
control diet that was adequate in energy, but slightly limiting in MP and detected 
increased urea-N concentration in serum, urine, and milk compared with the control diet. 
In the present study, supplementation of RPLys maintained MUN and NH3-N 
concentrations, indicating that the RPLys diets may have provided a more favorable AA 
balance and resulted in less deamination of absorbed AA.  
Urinary and fecal N excretion were not affected by dietary treatments. However, 
manure N excretion (urinary N excretion, g/d + fecal N excretion, g/d) decreased for the 
diNALL and the AP diets. Urinary and fecal N are directly correlated with DM and N 
intakes (Huhtanen et al., 2008). Therefore, because of the reduced N intake of animals 
fed the diNALL and the AP diets, manure N excretion decreased. The reduced manure N 
excretion in the current study indicates the potential use of supplementing diNALL to 
lactating dairy cows to aid in environmental N management on dairy farms, however 
further lactation trials are needed to determine how NALL products impact N utilization 
in lactating dairy cows. 
 
Ruminal Fermentation Characteristics 
 
Supplementation of RPLys in the NALL, the diNALL and the AP diets reduced 
ruminal pH and ranged from 6.15 to 6.23, compared to the CL diet (pH = 6.42; Table 2-
5). The mean ruminal pH from all dietary treatments were close to or above 6.2, so 




RPLys supplementation on ruminal pH is not well defined in the literature. Recently, Lee 
et al. (2015) determined that RPLys supplementation to an MP-deficient diet did not alter 
ruminal pH in mid-lactation dairy cows.  
Total and individual VFA concentrations were similar across dietary treatments. 
According to Lee et al. (2015), rumen fermentation variables (total and individual VFA) 
were not affected by RPLys supplementation to a MP-deficient diet. A previous study 
performed by our group (Menchu, 2019), estimated the ruminal escape for the NALL 
products used in the current study. The ruminal escape (% of dose) averaged 43.5 for 
both NALL products, indicating that the NALL chemical structure is altered in the rumen 
environment. The absence of response in VFA profiles to NALL and diNALL dietary 
treatments, suggests that NALL lacks a ruminal mode of action and further research is 




Results of the current study show that feeding the diNALL diet in mid to late 
lactation dairy cows decreased DMI, leading to greater feed efficiency compared to the 
CL diet. Milk composition, milk component yields, AA, and VFA profiles were not 
affected by RPLys supplementation. Net energy shifted toward milk production for the 
diNALL treatment. Rumen-protected Lys supplementation did not alter utilization of N 
by lactating Holstein dairy cows in the present study. These findings suggest that the 




diNALL showing the most benefit to improve feed efficiency. However, further research 
is needed to discover the role of Lys derivatives in lactating dairy cows on productive 
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Table 2-1. Ingredient and chemical composition of the experimental diets supplemented 
with rumen-protected lysine fed to lactating Holstein dairy cows (n = 40) 
Item 
Experimental diet1 
CL NALL diNALL AP 
Ingredient, % of DM     
Alfalfa hay 19.6 19.5 19.5 19.5 
Wheat straw 4.91 4.90 4.90 4.89 
Corn silage 26.4 26.4 26.4 26.3 
Corn grain (steam-flaked) 13.9 13.9 13.9 13.9 
Corn distillers grain 21.0 21.0 21.0 20.9 
Cottonseed, whole 4.86 4.84 4.84 4.83 
Beet pulp, shreds 6.54 6.53 6.53 6.52 
Lysine supplement2 − 0.20 0.25 0.40 
Sodium bicarbonate 0.63 0.63 0.63 0.63 
Vitamin and mineral mix3 2.11 2.10 2.10 2.09 
Chemical composition, % of DM     
DM, % 57.6 ± 1.88 58.1 ± 1.93 57.8 ± 2.74 58.2 ± 2.80 
OM 91.2 ± 0.38 91.3 ± 0.48 91.7 ± 1.22 91.1 ± 0.58 
CP  15.3 ± 0.20 15.4 ± 0.25 15.4 ± 0.51 15.4 ± 0.36 
RDP4  8.58 8.64 8.64 8.64 




NDF 34.6 ± 1.98 34.2 ± 2.46 34.3 ± 1.65 34.2 ± 2.99 
ADF 18.6 ± 1.37 18.0 ± 1.36 18.0 ± 0.90 18.0 ± 1.64 
Starch 19.5 ± 0.65 19.4 ± 1.02 19.4 ± 0.99 19.5 ± 0.54 
Ether extract 3.38 ± 1.06 4.58 ± 0.91 3.96 ± 1.39 4.10 ± 1.29 
NFC5 37.9 ± 2.56 37.1 ± 3.21 38.0 ± 3.10 37.4 ± 3.43 
NEL,
4 Mcal/kg 1.74 1.74 1.74 1.74 
Protein supply,6 g/d     
MP supply 2,910 2,930 2,930 2,930 
MP requirement 2,900 2,900 2,900 2,900 
MP balance 10 30 30 30 
Lys and Met balance,7 g/d     
dLys requirement 192 193 193 193 
dLys supplied by the diet 172 172 172 172 
dLys from Lys supplement 0 20 20 20 
Lys balance -20 -1 -1 -1 
dMet requirement 64 64 64 64 
dMet supplied by the diet 63 63 63 63 
Met balance -1 -1 -1 -1 





1CL= control diet; NALL = Control + NALL (CJ CheilJedang, Seoul, Korea); diNALL= 
Control + diNALL (CJ CheilJedang, Seoul, Korea); and AP = Control + AjiPro®-L v2 
(Ajinomoto, Japan). 
2Developmental NALL products (NALL and diNALL) (CJ CheilJedang, Seoul, Korea) 
and a commercial RPLys product (AjiPro®-L v2) (Ajinomoto, Japan) were used as the 
sources of rumen-protected lysine. 
3Formulated to contain (per kg DM): 226.7 mg of Se (from sodium selenite), 9278.7 mg of 
Cu (from copper amino acid complex), 40,537.4 mg of Zn (from zinc amino acid 
complex), 38,653.4 mg of Mn (from manganese amino acid complex), 552.6 mg of Co 
(from cobalt carbonate), 1,234,585.2 IU of vitamin A, 152,808.1 IU of vitamin D, 3,815.1 
IU of vitamin E, and 295 mg of Rumensin (Elanco Animal Health, Greenfield, IN). 
4Based on tabular value (NRC, 2001).  
5NFC = 100 – CP – NDF – ether extract – ash. 
6All values were estimated using NRC (2001) based on actual DMI, milk yield, milk 
composition, and BW of the cows throughout the trial. 
7Digestible Lys (dLys) and digestible Met (dMet) supply from the diets were estimated 
using NRC (2001); supply of dLys from RPLys products were estimated by data provided 
the manufacturer. Requirements of dLys and dMet were calculated as 6.6 and 2.2% 
(respectively) of MP requirements. 




Table 2-2. Dry matter intake, productive performance, body weight (BW) change, and 
net energy utilization of mid to late lactation Holstein dairy cows supplemented with 
rumen-protected lysine 
Item 
Diet1   
CL NALL diNALL AP SEM P 
Intake, kg/d       
DM 26.8b 26.1ab 24.7a 24.8a 0.41 < 0.01 
Yield, kg/d       
Milk 36.4 36.6 37.1 35.6 1.16 0.83 
3.5% FCM 36.2 36.5 35.8 35.6 1.83 0.98 
ECM 36.5 36.9 36.5 35.7 1.62 0.96 
Milk composition, %       
Fat 3.74 3.39 3.32 3.30 0.178 0.29 
True protein 3.05 3.00 2.98 3.05 0.101 0.95 
Lactose 4.88 4.72 4.79 4.85 0.055 0.17 
Milk component yield, 
kg/d 
      
Fat 1.29 1.26 1.22 1.23 0.086 0.91 
True protein 1.09 1.09 1.11 1.04 0.034 0.50 
Lactose 1.77 1.76 1.78 1.73 0.061 0.92 




Milk yield/DMI 1.33b 1.46ab 1.54a 1.46ab 0.046 0.02 
3.5% FCM yield/DMI 1.33 1.44 1.49 1.46 0.070 0.42 
ECM yield/DMI 1.35 1.45 1.51 1.47 0.061 0.30 
BW       
Initial, kg 745 758 730 735 18.9 0.36 
Mean, kg 769 772 730 746 18.8 0.35 
Gain, kg/d 1.74 1.08 0.10 1.02 0.661 0.39 
Calculated net energy 
values, Mcal/d 
      
Maintenance 11.7 11.7 11.2 11.4 0.21 0.35 
BW gain 8.89 5.50 0.51 5.22 3.38 0.39 
Milk 25.9 24.4 24.1 24.1 1.75 0.88 
BW gain + milk 34.7 29.9 24.6 29.3 3.03 0.15 
Total2 46.4 41.6 35.9 40.8 3.05 0.13 
NEL,
3 Mcal/kg of DMI 1.74 1.56 1.43 1.62 0.113 0.29 
Net energy partitioning,  
% energy intake 
   
Maintenance 27.1 29.3 34.6 29.0 2.52 0.20 
BW gain 12.3 10.3 -10.5 10.7 9.23 0.27 
Milk 60.6 60.4 75.8 60.3 7.18 0.35 





a-bMeans within a row with different superscripts differ (P < 0.05). 
1CL= control diet; NALL = Control + NALL (CJ CheilJedang, Seoul, Korea); 
diNALL= Control + diNALL (CJ CheilJedang, Seoul, Korea); and AP = Control + 
AjiPro®-L v2 (Ajinomoto, Japan). 
2Net energy used for maintenance, BW change, and milk. 




















Table 2-3. Plasma AA concentrations (µmol/L) of mid to late lactation Holstein dairy 
cows supplemented with rumen-protected lysine 
Item 
Diet1   
CL NALL diNALL AP SEM P 
Arg 48.9 53.1 48.8 54.2 3.09 0.49 
His 51.0 49.9 49.7 47.2 2.70 0.78 
Ile 88.7 86.8 80.5 88.4 5.61 0.71 
Leu 206 197 181 191 12.6 0.58 
Lys 71.6 78.7 66.5 77.6 4.71 0.24 
Met 20.7 20.7 20.3 20.5 1.04 0.99 
Phe 44.0 43.5 41.0 43.7 1.77 0.60 
Val 217 202 192 207 14.2 0.67 
EAA2 748 731 678 731 42.6 0.68 
Ala 251 237 247 235 10.6 0.65 
Gly 232 218 231 221 16.6 0.92 
Ser 81.9 81.5 77.7 81.2 5.12 0.72 
Tyr 55.9 55.3 51.6 57.6 3.58 0.68 
NEAA3 621 609 607 595 28.1 0.93 
 
1CL= control diet; NALL = Control + NALL (CJ CheilJedang, Seoul, Korea); 
diNALL= Control + diNALL (CJ CheilJedang, Seoul, Korea); and AP = Control + 




2Essential amino acid analyzed. 
























Table 2-4. Utilization of N by mid to late lactation Holstein dairy cows supplemented 
with rumen-protected lysine 
Item 
Diet1   
CL NALL diNALL AP SEM P 
N intake, g/d 613b 611b 583a 580a 10.1 0.04 
Milk N,2 g/d 189 184 185 188 10.6 0.99 
Milk N:N intake3 0.31 0.30 0.32 0.33 0.017 0.75 
MUN, mg/100 mL 11.2 11.1 11.3 11.6 0.33 0.74 
NH3-N
4, mg/100 mL 11.4 11.1 11.9 11.3 0.48 0.70 
Urinary N excretion,5 g/d 224 223 216 225 9.40 0.90 
Fecal N excretion,6 g/d 201 204 182 167 12.0 0.12 
Manure N excretion,7 g/d 424b 427b 398a 392a 12.0 0.10 
 
a-bMeans within a row with different superscripts differ (P < 0.05). 
1CL= control diet; NALL = Control + NALL (CJ CheilJedang, Seoul, Korea); 
diNALL= Control + diNALL (CJ CheilJedang, Seoul, Korea); and AP = Control + 
AjiPro®-L v2 (Ajinomoto, Japan). 
2Milk N (kg/d) = milk true protein (kg/d)/6.38 + MUN (kg/d). 
3Efficiency of use of feed N to milk N. 
4Ruminal ammonia-N. 





6Predicted using the equation: N intake, g/d – urinary N excretion, g/d – milk N, g/d. 























Table 2-5. Ruminal fermentation characteristics of mid to late lactation Holstein dairy 
cows supplemented with rumen-protected lysine 
Item 
Diet1   
CL NALL diNALL AP SEM P 
Ruminal pH 6.42a 6.23b 6.18b 6.15b 0.06 0.02 
Total VFA, mM 96.5 98.2 97.0 98.2 5.5 0.53 
Individual VFA, mM       
     Acetate (A) 57.5 56.5 57.9 58.4 1.03 0.59 
     Propionate (P) 25.4 28.4 26.4 26.8 0.89 0.15 
     Butyrate 10.4 10.1 9.6 9.8 0.44 0.19 
     Valerate 1.53 1.57 1.52 1.50 0.07 0.60 
     Isobutyrate 0.87 0.83 0.86 0.92 0.05 0.22 
     Isovalerate 0.83 0.84 0.70 0.74 0.07 0.38 
A:P 2.35 2.05 2.24 2.25 0.10 0.25 
 
a,bMeans within a row with different superscripts differ (P < 0.05). 
1CL= control diet; NALL = Control + NALL (CJ CheilJedang, Seoul, Korea); 
diNALL= Control + diNALL (CJ CheilJedang, Seoul, Korea); and AP = Control + 









Bioavailability and lactational performance of dairy cows supplemented with N-




The present study investigated the bioavailability and lactational performance of dairy 
cows supplemented with N-acetyl-L-Met (NALM) at different doses. Six lactating dairy 
cows (75  20.1 d-in-milk) were blocked by parity and d-in-milk. The experiment was 
performed as a replicated 3 × 3 Latin square design. Within each square, cows were 
randomly assigned to a sequence of 3 diets during each of the three 13-d periods (10 d of 
treatment adaptation and 3 d of data collection and sampling). The 3 dietary treatments 
are as follows: basal diet (15.7% CP) without NALM (control); control diet with 30 g/d 
of supplemented NALM (30NALM), and control diet with 60 g/d of supplemented 
NALM (60NALM). The NALM was rumen dosed for 11 d and then abomasally infused 
on d 12 and d 13 for quantification of NALM bioavailability (BA). Supplementation of 
NALM did not affect dry matter intake, milk production parameters, or feed efficiency. 
Supplementation of NALM led to a quadratic trend (P = 0.06) toward increases in plasma 
Arg, Gly, and Met concentrations and quadratic increases in plasma His and Ser 
concentrations. Rumen NALM dosing led to a quadratic increase in the baseline mean 




curve (AUC) versus control and both linear and quadratic increases in AUC were 
observed with NALM dosing. The mean AUC per Met unit (µM × h/L ÷ Met (g)) for the 
control, 30NALM, and 60NALM were 4.68, 5.89, and 5.07, which corresponded to a Met 
BA (AUC per Met unit ÷ AUC per Met unitControl) of 100, 139, and 115%, respectively. 
The absence of plasma NALM and increases in plasma Met for both ruminal and 
abomasal NALM dosing in the current study suggests that NALM supplemented by 
either rumen placement or abomasal infusion to lactating dairy cows may have been 
deacetylated before entering the central circulation. In the current study, BA estimation 
by plasma Met was greater for NALM doses, indicating NALM improved plasma Met 
concentrations relative to the control. The absence of NALM in plasma, liver, milk, and 
muscle reveals that the N-acetyl group is cleaved from NALM prior to reaching central 
circulation and should be considered as a safe and effective BA rumen-protected Met 
source in lactating dairy cows.  





Protein nutrition of dairy cows in recent years has shifted from the simple use of 
dietary CP towards meeting the ammonia and AA needs of ruminal fermentation for 
MCP synthesis (Schwab and Broderick, 2017), while providing specific bypass AAs. 




lactational performance, meet AA requirements of the cow, and deliver consistent post-
ruminal AA, while minimizing total dietary CP supply (Lee et al., 2012a). When excess 
CP is fed and the AA profile within the CP supply does not match animal AA 
requirements, increases in environmental N excretion will result (Liu et al., 2017). 
Because Lys and Met have traditionally been recognized as the most limiting AA for 
lactating dairy cows (Schwab et al., 1992), research has focused on Met and Lys dietary 
supply in order to maximize milk production and milk component synthesis. However, 
balancing rations for only Lys and Met requirements may not improve productive 
responses, because additive effects of other AAs may be overlooked. Therefore, 
balancing rations for EAA requirements of dairy cows (not just Lys and Met) and for 
multiple-limiting AA may help to reduce overfeeding of protein, improve post-ruminal 
AA absorptive efficiency, reduce N excretion, and improve lactational performance (Liu 
et al., 2017). 
Protection of free AAs from ruminal degradation dates to the 1960s when researchers 
began to understand the importance of balancing AA in order to meet dairy cow AA 
requirements (Schwab and Broderick, 2017). Numerous physically protected (coated or 
encapsulated) and chemical forms (Met analogues) of rumen-protected Met (RPMet) 
have been developed to escape ruminal degradation and provide post-ruminal digestible 
Met (dMet) for intestinal absorption (Schwab and Ordway, 2003). Production responses 
to supplemental RPMet products have been inconsistent and the biological mechanisms 




supplementing cows with RPMet products generally result in increased milk fat and 
protein yields (Zanton et al., 2014). 
Recently, a new form of RPMet, a Met derivative, N-acetyl-L-Met (NALM) has been 
shown to increase milk fat composition and yield (Fagundes et al., 2018). 
Supplementation of NALM to early and mid-lactation dairy cows improved milk yield 
(Liang et al., 2019; Amaro et al., 2019). The studies note that NALM supplementation at 
30 g/d resulted in the highest milk yield and these studies represent the initial attempts to 
measure production responses to supplemental NALM in lactating dairy cows.  
The NALM is a Met derivative produced by chemical protection of the L-Met α-
amino group with a N-acetyl group. In monogastric animals, the L-Met from NALM is 
metabolically equivalent to free L-Met (Rotruck and Boggs, 1975). Several animal 
studies conclude that the bioavailability (BA) of L-Met and NALM are similar based on 
feeding studies measuring growth rates and weight gain (Boggs et al., 1975; Young 
Jenkins et al., 1978; Friedman and Gumbmann, 1987). To date, there is no research 
reported on the effects of supplementing NALM to lactating dairy cows on BA. 
Therefore, the objective of this study was to evaluate the BA and lactational performance 
of lactating dairy cows supplemented with NALM at 2 different doses. We hypothesized 
that Met supply from abomasal infusion of NALM would increase plasma Met 
concentration and the BA of NALM would be greater for each NALM dose compared to 





MATERIALS AND METHODS 
 
The dairy cows used in the present study were cared for according to the Live Animal 
Use in Research Guidelines of the Institutional Animal Care and Use Committee at Utah 
State University. The study was conducted at the Caine Dairy Research Center 
(Wellsville, UT), Utah State University from March to May, 2019. 
 
Cows, Experimental Design, and Diets 
 
Three multiparous and three primiparous lactating Holstein dairy cows fitted with a 
rumen cannula were used in the trial. Cows began the experiment averaging 75 ± 20.1 
DIM with 32.7 ± 5.28 kg/d of milk yield. The experiment was performed in a replicated 3 
× 3 Latin square design. Within each square, cows were randomly assigned to a sequence 
of 3 diets during each of the three 13-d periods (10 d of treatment adaptation and 3 d of 
data collection and sampling). A washout period of 7 d was assigned before the start of 
subsequent periods to avoid carryover effects. Within each square, cows were randomly 
assigned to a sequence of 3 dietary treatments: basal diet (15.7% CP) without NALM 
(control); control diet with 30 g/d of supplemented NALM (30NALM), and control diet 
with 60 g/d of supplemented NALM (60NALM; Table 3-1). 
The developmental NALM product from CJ CheilJedang (Seoul, South Korea) was 




powder form, and contained Met concentration of 78.0%, with 99.5% purity. The NALM 
product was added at a rate determined for cows to consume 30 and 60 g/cow/d of Met in 
order to supply 15.6 and 31.2 g of dMet to the small intestine according to 
manufacturer’s recommendation, respectively. The rates were also based on previous 
research (Liang et al., 2019) and the 30 g/cow/d rate tested by Fagundes et al., (2018). 
The recommendation of required digestible Lys and Met were assumed as 6.6 and 2.2% 
of the MP requirements, respectively (NRC, 2001; Table 3-2). The NALM product was 
placed through the rumen cannula at the liquid phase just under the rumen fiber mat daily 
at 0700 h during the 10 d of treatment adaptation and 1 d of data collection and sampling.  
Diets were formulated based on the NRC recommendations to provide sufficient NEL, 
ME, MP, minerals, and vitamins with an estimated DMI of 25.0 kg/d to produce 40 kg/d 
of milk with 3.8% fat and 3.0% true protein (NRC, 2001; Table 3-2). The basal diet was 
also formulated to balance Lys (2.0 g/d) and Met (0 g/d) recommendations according to 
NRC (2001). Cows were housed individually in tie stalls fitted with rubber mattresses 
covered with straw, allowing free access to water. Cows were individually fed twice daily 
for ad libitum intake at a level of 110% expected daily intake with 60% of allotted feed 
fed at 0600 h and 40% fed at 1500 h. Feed offered and refused was recorded daily, and 
feed samples were taken during the sampling week to determine DMI. Cows were milked 






Feed and Milk Samplings and Analyses 
 
Samples of alfalfa hay and corn silage were taken weekly to determine DM, and diets 
were adjusted accordingly for change in DM concentration. Samples were ground to pass 
a 1-mm screen (standard model 4; Arthur H. Thomas Co., Swedesboro, NJ), and stored 
for chemical analysis. Samples of TMR and orts were collected from individual cows on 
d 11 to d 13, composited by period, dried at 60°C for 48 h, and ground as previously 
described. The DM concentrations of samples were used to calculate intakes of DM and 
nutrients. 
Analytical DM concentration of samples was determined by oven-drying overnight at 
105 °C. Concentration of CP was determined using an automated N combustion analyzer 
(Elementar, Analysensysteme GmbH, Hanau, Germany; AOAC, 2000; method 968.06). 
Concentrations of NDF and ADF were sequentially determined using a fiber analyzer 
(200/220, ANKOM Technology, Macedon, NY) according to the methodology supplied 
by the company, which is based on the methods described by Van Soest et al. (1991). 
Ether extract was measured using a fat analyzer (XT20, ANKOM Technology; AOAC, 
2000; method 2003.05). In addition, samples of TMR were analyzed for starch by 
Cumberland Valley Analytical Services (Waynesboro, PA).  
Milk was sampled for 3 consecutive d (d 11 to 13) during the a.m. and p.m. milkings 
each period. Individual milk samples were analyzed by the Rocky Mountain DHIA 
Laboratory (Providence, UT) for fat, true protein, lactose, and milk urea nitrogen (MUN). 




fat and protein yields were calculated by multiplying milk yield from the respective day 
by fat and true protein concentration of the milk from an individual cow. A subset of milk 
samples from d 11 to d 13 of each period were freeze-dried, composited by cow, and 
stored for NALM and Met analysis by Bio Research Institute, CJ CheilJedang (Suwon, 
South Korea). 
 
BA, AA, and Plasma NALM Analyses 
 
To determine the BA of NALM, 15.6 g (30 g oral equivalent) or 31.2 g (60 g oral 
equivalent) of NALM was suspended in 1 L of water and bolus infused into the 
abomasum over 5 min at 0700 h on d 12 and 13 of each sampling period. An infusion line 
(Nalgene 980® braided clear PVC tubing; 6.4 mm i.d., 2.3 mm wall; Fisher Scientific, 
Waltham, MA) containing a distal flange (Spires et al., 1975) was passed through the 
sulcus omasi and placed in the abomasum via the abomasal orifice with an insertion and 
delivery device as described by Gressley et al., (2006). Infusion line placement was 
assured by hand to confirm the flange was in the abomasum and not the omasum. After 
the NALM bolus administration, the infusion line was rinsed with 250 mL of water to 
ensure full delivery of the NALM dose to the abomasum. Control infusion consisted of 
1.25 L of water bolus infused into the abomasum.  
Indwelling catheters were placed in the jugular vein after the a.m. milking on d 11 of 
each sampling period and catheter placement altered each period. Catheters were 




collected on d 11 at 0, 2, 4, 6, 8, and 10 h after rumen NALM dosing into 10-mL EDTA 
plasma vacuum tubes. The blood samples taken on d 11 were used to establish individual 
basal plasma Met concentration for each test animal before abomasal infusions on d 12 
and d 13. Blood samples were collected on d 12 at 0, 1, 2, 3, 4, 5, 7, 9, 11, 13, 15 h and 
on d 13 at 0, 2, 4, 6, 8 and 10 h after NALM abomasal infusion into 10-mL EDTA 
plasma vacuum tubes. Samples were placed on ice and centrifuged at 2,300 × g for 20 
min, after each sampling timepoint, and plasma was collected and stored at ‒40°C for 
subsequent plasma Met, NALM, and AA analyses. The plasma samples were prepared 
for AA and NALM analysis by filtration using an Amicon Ultra-0.5 Centrifugal Filter 
Unit (3KDa cutoff; Cat # UFC5003BK, Millipore, Burlington, MA) to remove plasma 
proteins. Flow-through samples were analyzed for Met and NALM using UPLC 
(Shimadzu Nexera, Seoul, South Korea). 
Methionine BA of the NALM dose was determined from the plasma Met area under 
the curve (AUC) with respect to time for d 12 and 13 of each sampling period. The AUC 
was numerically estimated using the trapezoidal rule after subtraction of the mean of the 
pre-infusion concentrations from all values. The AUC was then expressed per gram of 
total Met concentration in the diet (AUC per Met unit). The ratio of the NALM dose (30 
g or 60 g) AUC per Met unit over the control AUC per Met unit represented the Met BA 
of the NALM dose to the control. The NALM dose abomasally infused was adjusted for 
ruminal loss (33%), Met content (78%), purity (99.5%), and therefore the resulting AUC 
per Met Unit was expressed over the control for Met BA estimation of NALM. The 




supplied in the control diet is available to the animal for absorption. Results of BA were 
expressed as the mean percentage of the amount of Met supplied by NALM.  
 
Liver and Muscle Biopsies 
 
Liver and muscle biopsy samples were collected on d 12 of each sampling period post 
a.m. feeding. Liver biopsies were collected by the paracostal, percutaneous needle biopsy 
method as described by Mølgaard et al. (2012). Muscle biopsies were collected by 
surgical excision of a 1 cm3 M. longissimus dorsi sample, dorsal to the last rib under local 
anesthesia as described by Bradley (1978). Liver and muscle biopsy samples were freeze-
dried and stored for tissue NALM and Met analysis by Bio Research Institute, CJ 
CheilJedang. 
 
Tissue and Milk NALM and Met Analyses 
 
Freeze-dried muscle (approximately 50 mg) and liver samples (liver sample was used 
in its entirety) were weighed and added to a lysis buffer consisting of 100 mM perchloric 
acid for muscle (700 µL) and liver (200 µL) and soaked at 4°C for 20 min. A tissue 
homogenizer pestle (Biomasher II® Closed System Disposable Tissue Homogenizer, 
NIPPI Inc., Tokyo, Japan) was used to crush the tissue samples and then the suspension 
was centrifuged at 13,000 × g for 15 min. The supernatant was collected and pH adjusted 




Met concentrations using a UPLC (Shimadzu Nexera) system as described by Hyde et al., 
(2004). Freeze-dried milk samples were dissolved in water (25 w%, 37°C) and then 
filtered using an Amicon Ultra-0.5 Centrifugal Filter Unit (3KDa cutoff; Cat # 
UFC5003BK, Millipore). Flow-through samples were analyzed for Met and NALM using 




Data were analyzed as a replicated 3 × 3 Latin square using the Proc Mixed procedure 
of SAS (version 9.4; SAS Institute Inc., Cary, NC). Data for intake, milk production, and 
AUC were analyzed with a model that included fixed effects of period and treatment. 
Cow nested within square and square were random effects. Data for AA were analyzed 
using the model described above except that time was included as a repeated option. For 
each variable analyzed, 3 covariance structures (autoregressive order 1, compound 
symmetry, and unstructured covariance) were evaluated. The covariance structure that 
resulted in the lowest values for the Akaike information criterion and the Schwartz 
Bayesian criterion was used (Littell et al., 1998). Kenward-Roger's option was used to 
calculate the denominator degrees of freedom. Means were separated by use of 
orthogonal polynomial contrasts: 1) control vs. NALM treatments, 2) linear effect of 
increasing NALM, and 3) quadratic effect of increasing NALM. Least square means are 
reported throughout. Differences were considered significant at P ≤ 0.05, and trends were 




RESULTS AND DISCUSSION 
 
Characteristics of Diet Composition and Treatment 
 
Ingredients and chemical composition of the basal diet are presented in Table 3-1. 
Energy and protein supply and AA balance of the basal diet supplemented with NALM 
are presented in Table 3-2. The basal diet was formulated to contain 15.7% CP and 
provide adequate MP supply (60 g/d). All diets provided MP supply in excess of 
requirements. Additionally, all diets were isoenergetic and supplied NEL and ME in 
excess of requirement (NRC, 2001). Lysine and Met requirements were met for the basal 
diet (2.0 g/d and 0 g/d balance) by dietary addition of canola meal, dried distillers grains 
with solubles, and blood meal, respectively. The Met balance for NALM supplemented 
diets were 15.6 and 31.2 g/d for the 30NALM and 60NALM, respectively.  
The NRC (2001) model recommends that dLys and dMet concentrations in MP for 
maintenance and optimal milk protein production approximate to 7.2 and 2.4%, 
respectively. Common dietary strategies to achieve ideal Lys and Met concentrations 
include feeding diets with greater CP concentration or supplementing RPLys and RPMet 
products to diets with lower CP concentration to balance dLys and dMet in MP. Feeding 
higher CP diets can result in excess ruminal AA supply, greater N excretion in the 
environment, reduced N efficiency, and increase feed costs, which is economically 




An alternative approach to optimize milk protein production is to maintain dLys and 
dMet in MP closer to 6.6 and 2.2%, respectively, for a targeted dLys:dMet in MP 
(efficiency for AA use) close to 3.0:1 (Schwab et al., 2003). Van Amburgh et al. (2015) 
updated the CNCPS model (version 6.5) and reported optimal ratios of dLys:dMet in MP 
closer to 2.69:1. The authors stated that to maximize milk protein yield, the calculated 
estimates from breakpoint analysis in the updated CNCPS model for Lys and Met (% of 
MP) were 7.00 and 2.60%, respectively, and to maximize milk protein content, 6.77 and 
2.85 (% of MP), respectively (Van Amburgh et al., 2015). In the current study, 
supplementing 30 g/d (30NALM; manufacturer’s recommended dose) and 60 g/d of 
NALM decreased the dLys:dMet in MP to 2.46:1 and 2.05:1 (Table 3-2), respectively. In 
addition, the dLys and dMet in MP were 6.53 and 2.66%, respectively, for the 30NALM 
diet. Furthermore, the dLys and dMet in MP were 6.49 and 3.17%, respectively, for the 
60NALM diet. Supplementation of 30 g/d NALM improved the dMet in MP, which 
suggests a more favorable Met concentration in the diet for animal and production 
utilization. However, increasing the supplemental NALM dose to 60 g/d reduced the 
dLys and increased the dMet in MP, leading to suboptimal dLys:dMet in MP.    
 
Feed Intake, Productive Performance, Feed Efficiency, and Milk Urea Nitrogen 
 
Intake, milk production, feed efficiency, and MUN data are presented in Table 3-3. 
Although primary production parameters were measured in the present study, caution 




intake, productive performance, and feed efficiency were not affected by NALM 
supplementation, however MUN linearly decreased with NALM supplementation. The 
basal diet was formulated to provide adequate MP and the dLys and dMet in MP were not 
limiting, which may partly explain the lack of response to treatments. A common in vivo 
technique to measure BA of AA in lactating dairy cows is the production response 
approach (Schwab et al. 2001; Fleming et al., 2019). Whitehouse et al. (2017) suggested 
the major limitation for the production response approach is to maintain dietary AA (Met 
or Lys) deficiency, in all animals, over all treatment dosages administered, so that 
linearity in milk protein concentration or yield is detected. Although the production 
response approach was not used in the current study, the absence of positive milk protein 
response to increasing NALM doses further supports that the basal diet was adequate in 
dMet, which was expected. The lack of negative production parameter effects serves to 
indicate that supplementation at 60NALM was still a safe concentration for the animals. 
Liang et al. (2019) reported that NALM supplemented at rates of 0, 15, 30 and 60 g/d 
to mid lactation dairy cows improved milk yield in a quadratic manner, with 30 g/d of 
NALM seeming to be the optimal supplementation rate for milk yield under the 
experimental conditions. Amaro et al. (2019) found that milk yield of early lactating 
Holstein dairy cows tended to be greater (P = 0.07) with intermediate concentrations (15 
and 30 g/d) of NALM compared to control animals. The authors noted that NALM 
supplementation at 30 g/d resulted in the highest numerical milk yield (Amaro et al., 
2019), which is in agreement with Liang et al. (2019). Based on limited data in the 




to exhibit beneficial effects on milk protein concentrations (Amaro et al., 2019; Liang et 
al., 2019). However, Fagundes et al. (2018) reported that NALM supplementation at 30 
g/d increased milk fat concentration and yield and 3.5% FCM yield in MP-deficient (-190 
g/d) and MP-adequate diets (50 g/d). The basal diet fed in the current study was similar in 
MP (60 g/d) to that fed by Fagundes et al. (2018); however, each square within the Latin 
square design consisted of 21-d periods versus 13-d periods for the current study, 
respectively. Therefore, the short trial length in the present study, along with a 7-d 
washout period may not have allowed animals to adapt to NALM supplementation to 
exhibit changes in production parameters.  
Liang et al. (2019) noted that MUN concentrations were not affected by oral NALM 
supplemented at rates of 0, 15, 30 and 60 g/d to mid lactation dairy cows. Milk urea 
nitrogen can be used as an indicator of N utilization efficiency in dairy cows. Variation in 
MUN is related to the protein:energy ratio of the diet consumed. With adequate energy in 
the diet, MUN can be indicative of protein status. All diets in the current study were 
balanced to be isoenergetic and supplied NEL and ME in excess of requirement (Table 3-
2). The linear decrease in MUN concentrations due to NALM dosing was unexpected, 
however once NALM reaches the small intestine it is deacetylated into the physiological 
isomer L-Met that is systemically available for use by the body. Although it appears that 
NALM dosing improved N utilization efficiency through reduced MUN content, milk 
true protein was similar among NALM dosage rates. Lack of milk true protein change 
suggests the free useable Met from NALM dosing may have been utilized for other 




NALM supplementation alters N utilization of early to mid-lactation dairy cows by oral 
supplementation, as abomasal infusion of RPAAs is not a practical means of supplying 
RPAAs to lactating dairy cows.  
 
Plasma AA Profiles and NALM 
 
Supplementation of NALM led to a quadratic trend (P = 0.06) toward increases in 
plasma Arg, Gly, and Met and quadratic increases in plasma His and Ser concentrations 
(Table 3-4). Alternatively, NALM supplementation linearly decreased plasma AA 
concentrations of Leu, Phe, and Val and trends were observed for linear decreases in Ile 
and Ala concentrations. Although plasma Met increased linearly, there was an overall 
linear trend (P = 0.08) toward lower plasma EAA concentration. Total NEAA 
concentration was not affected by supplementation of NALM. Recently, Liang et al. 
(2019) described that NALM supplemented at rates of 0, 15, 30, and 60 g/d to mid 
lactation dairy cows displayed quadratic increases in plasma Met concentration, with 30 
g/d NALM resulting in the highest plasma Met concentration compared to the control 
treatment (36.7 vs. 31.1 µM). In contrast, Fagundes et al. (2018) found that early to mid-
lactation dairy cows supplemented with 30 g/d NALM to MP-adequate diets had no 
effect on plasma Met concentration, which was an unexpected finding to the authors.  
Plasma Met concentrations provide a qualitative measure of post-ruminal delivery 
and absorption of Met from RPMet products (Blum et al., 1999). Furthermore, plasma 




utilization (Meijer et al., 1995). However, the ability of NALM to be absorbed as L-Met 
from the small intestine is dependent on the enzyme acylase I, which hydrolyzes NALM 
to L-Met (Giardina, 1997; Baxter et al., 2002). The acylase I enzyme is found in the 
intestine, liver, and kidney of mammalian tissues and has a high affinity for sulfur and 
neutral AA derivates (Giardina et al., 1997). No NALM could be detected in either portal 
or vena caval plasma in young pigs dosed with NALM by a gastrostomy tube (382 mg/kg 
BW), suggesting deacylation of NALM in the intestinal lumen or mucosal cells (Daabees 
et al., 1984). In addition, no NALM was detected in the plasma of adult subjects or 1-
year-old infants after oral loading (0.0605 mmoles/kg BW) with NALM (Stegink et al., 
1980; Stegink et al., 1982). The absence of plasma NALM (Table 3-5) and subsequent 
increase in plasma Met concentration with NALM dosing in the current study suggests 
that NALM supplemented by either rumen placement or abomasal infusion to lactating 
dairy cows is deacylated before entering the central circulation. 
In this study, NALM supplementation linearly decreased plasma branched-chain AA 
(BCAA; Ile, Leu and Val) and EAA concentrations. Appuhamy et al. (2011) reported that 
jugular infusion of a combination of L-Lys and L-Met led to a 17% reduction in plasma 
Ile concentration compared to control cows. Blum et al. (1999) noted that plasma 
concentrations of Val, Ile, and total BCAA were reduced, but only in cows fed a polymer 
coated RPMet product. Similarly, Fagundes et al. (2018) observed decreased plasma 
BCAA and total EAA concentrations, but only in a diet supplemented with NALM that 
was adequate in MP, which was similar to the diet and findings of the current study. In 




lactation cows. The authors found that the concentration of total BCAA and each 
individual BCAA (Ile, Leu, and Val) in plasma decreased linearly with abomasal infusion 
of DL-Met (Varvikko et al., 1999).  
The NALM supplementation in the current study most likely increased BCAA 
catabolism or tissue uptake, since EAAs that are not removed by the liver or peripheral 
tissues return to general circulation (Arriola Apelo et al., 2014). Branched-chain amino 
acids make up roughly 50% of the EAA in milk proteins (Mackle et al., 1999). Feeding 
RPMet products may result in increased milk protein synthesis or yield, because Met is a 
limiting EAA in dairy cows. Likewise, increased milk protein yield can enhance 
mammary gland BCAA uptake, leading to decreased plasma BCAA concentrations. Milk 
protein yield was not altered by NALM supplementation in our trial, thus suggesting that 
NALM dosing did not alter BCAA metabolism in the mammary gland. Branched-chain 
AAs and Met are important in portal drained viscera energy generation in ruminants 
(Lobley et al., 2003), and dietary energy deficiencies can alter AA partitioning towards 
greater oxidation and energy generation (Lapierre et al., 2006). All diets in the present 
study supplied ME and NEL in excess of requirements according to NRC (2001). 
Therefore, it is unlikely that the BCAAs were used for additional energy generation in 
tissues after NALM dosing. It appears that NALM supplementation to lactating dairy 
cows increases plasma Met concentration and alters individual plasma BCAA profiles; 
however, more research is needed to understand the mechanisms involved in BCAA 





BA and Kinetic Parameters 
 
Bioavailability and kinetic parameter results of NALM dosing are presented in Table 
3-5. The mean basal plasma Met concentration was 25.4 µM for the control diet, which is 
similar to observed values in the literature for lactating dairy cows (Appuhamy et al, 
2011; Arriola Apelo et al, 2014). Rumen NALM dosing led to a quadratic increase in the 
mean plasma Met concentration on d 11 of sampling after 10 d of rumen dosing. The 
mean plasma Met was 39.7 µM and 39.5 µM for the 30NALM and the 60NALM 
supplemented cows, respectively. The values reported in the current study were greater 
than literature values reported for diets supplemented with other types of RPMet products 
(Lee et al., 2015; Giallongo et al., 2016) and jugular infusion of L-Met to lactating dairy 
cows (Appuhamy et al, 2011), but similar to values seen with diets supplemented with 
NALM (Liang et al., 2019). Increased mean plasma Met after rumen NALM dosing 
suggests that NALM is deacetylated and free Met is absorbed into the central circulation 
for utilization by the animals.  
Peak time and Met height after abomasal infusion of NALM did not differ among 
treatments (Table 3-5). Plasma Met concentrations increased over the first 3 h after 
abomasal infusion of NALM and returned to basal concentrations by 8 h post dosing 
(Figure 3-1). Daabees et al. (1984) noted when equimolar amounts of L-Met and NALM 
were supplemented to young pigs, the portal and venal caval peak plasma Met 
concentrations were lower for NALM compared to L-Met. However, peak time after 




NALM versus portal (45 min) and vena caval (60 min) plasma Met concentrations after 
L-Met dosing (Daabees et al., 1984). In humans, peak time after oral administration was 
delayed for NALM compared to L-Met (Stegink et al., 1980). Peak time after 
intraruminal supplementation (50 g/d Met equivalent) with either the isopropyl ester of 2-
hydroxy-4-(methylthio)-butanoic acid or polymer coated RPMet product in non-lactating 
dairy cows, averaged 4 h and 22 h 25 min, respectively (Graulet et al., 2005).   
The mean plasma Met concentrations after abomasal infusion of each cow on d 12 
and 13 for each period were used to determine the AUC (Table 3-5). Abomasal infusion 
with NALM led to an increased AUC versus control and both linear and quadratic 
increases in AUC were observed with NALM dosing. The resulting AUC values were 
expressed as the AUC per Met unit (i.e., AUC divided by the total dMet concentration in 
each diet) in order to adjust for varying Met doses in the diets. The mean AUC per Met 
unit (µM × h/L ÷ Met (g)) for the control, 30NALM, and 60NALM diets were 4.68, 5.89, 
and 5.07, which corresponded to a Met BA (AUC per Met unit ÷ AUC per Met unitControl) 
of 100, 139, and 115%, respectively. N-acetyl-L-Met has been shown to be BA and 
capable of replacing the dietary requirement for Met in humans, rats, and swine, but had 
not been studied in dairy cattle (Boggs et al. 1975; Rotruck and Boggs 1975; Zezulka and 
Calloway, 1976; Stegink et al. 1980, 1982; Daabees et al. 1984). In the current study, BA 
estimation by plasma Met appearance was higher for NALM doses, indicating NALM 
improved plasma Met concentrations relative to the control. These results indicate that 
NALM is also capable of replacing dietary Met in lactating dairy cattle. However, further 




dairy cows relative to unprotected forms of Met (L-Met) and RPMet products with 
known BA values in the literature. To our knowledge, this is the first time the Met 
derivative, NALM has been shown to increase plasma Met concentrations and serve as a 




Residue potential in lactating Holstein dairy cows supplemented with NALM is 
summarized in Table 3-6. No NALM was detected in milk, liver, or muscle samples after 
rumen placement or abomasal infusion. In humans, existing authorizations for NALM 
have been approved in Germany for use in dietetic foods (BGBI, 1988) and in 1978, the 
United States approved NALM as a source of L-Met food additive (Federal Register, 
1978). Smith et al. (2011) described that the extraction efficiency of N-acetylated AAs is 
known to be poor which can lead to a lack of detection of NALM. Therefore, tissue Met 
concentrations were quantified to verify the NALM analysis method by intracellular 
disruption and tissue Met release. Milk Met concentration was not altered by NALM 
supplementation. Methionine extraction by the mammary gland, unlike Lys, closely 
matches the amounts required for milk protein synthesis (Bequette et al., 1998). 
Therefore, no improvement in milk protein yield due to NALM supplementation would 
explain the lack of change in milk Met after NALM dosing. Liver and muscle Met 
concentrations increased with NALM supplementation, resulting in both linear and 




increased muscle Met concentration. The liver is responsible for Met metabolism 
(Brosnan and Brosnan, 2006) and liver Met removal in dairy cows is related to total liver 
inflow and blood flow, rather than net portal absorption (Lapierre et al, 2005; Arriola 
Apelo et al, 2014). Additionally, hepatic Met removal varies with the source of RPMet 
supplemented to lactating dairy cows. Common RPMet products contain equimolar 
mixtures of D- and L- isomers; however, D-Met is not physiologically functional in the 
dairy cow and must be converted to L-Met before it can be incorporated into mammalian 
proteins (Lapierre et al., 2005; Lapierre et al., 2012). Since, NALM only contains the L- 
isomer of Met, it can be utilized directly for protein synthesis after deacetylation, without 
conversion to any other isoforms. Liver and muscle Met increased after NALM dosing, 
demonstrating that free Met from the NALM source was absorbed, delivered to the liver, 
and was able to be utilized by peripheral tissues (i.e, muscle). Furthermore, in lactating 
dairy cows, the primary net user of post-liver Met supply is the mammary gland for milk 
protein synthesis (Lapierre et al., 2005). Elevated Met concentrations in liver and muscle 
after NALM supplementation, could be explained by the lack of response to milk protein 
yield seen in the current study. The absence of NALM residue in plasma (Table 3-5), 
liver, milk, and muscle reveal that the N-acetyl group is cleaved from NALM prior to 
reaching central circulation and can be considered as a safe and effective RPMet source 







The current study evaluated the BA and lactational performance of dairy cows 
supplemented with NALM at 2 different doses. Overall, production parameters were not 
influenced by NALM supplementation, which was not surprising given the short study 
periods. Plasma Met increased with NALM dosing, while individual BCAA 
concentrations decreased. Bioavailability by plasma appearance of Met for NALM 
treatments was higher for the 30NALM dose compared with the 60NALM and the 
control, suggesting that optimal supplementation rate for NALM would be 30 g/cow per 
day. Residue of NALM was not detected in plasma, milk, liver, or muscle samples. This 
is the first attempt to measure the BA of the Met derivative in lactating dairy cattle and 
the findings suggest that NALM is deacetylated before reaching central circulation, 
increases plasma Met concentrations, and supplies lactating dairy cows with a source of 
RPMet. However, further studies are needed to evaluate the comparative BA of NALM 
in lactating dairy cows relative to unprotected forms of Met (L-Met) and RPMet products 
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Table 3-1. Ingredients and chemical composition of the basal diet 
Item % of DM 
Ingredient  
Alfalfa hay 30.0 
Wheat straw 1.77 
Corn silage 26.5 
Corn grain (steam-flaked) 15.9 
Distillers dried grains with solubles 3.54 
Cottonseed, whole 3.54 
Canola meal 7.07 
Blood meal 1.06 
Beet pulp, shreds 6.19 
Fat supplement1 1.77 
Sodium bicarbonate 0.53 
Yeast supplement2 0.18 
Vitamin and mineral mix3 1.94 
Chemical composition  
DM, % 60.5 
CP  15.7 
RDP4 9.33 












1Rumen-protected dry fat supplement (Nurisol®, WLT Distributors Inc., Winnipeg, MB, 
Canada). 
2Diamond V XP® (Cargill Inc., Cedar Rapids, IA). 
3Formulated to contain (per kg DM): 226.7 mg of Se (from sodium selenite), 9278.7 mg of 
Cu (from copper amino acid complex), 40,537.4 mg of Zn (from zinc amino acid 
complex), 38,653.4 mg of Mn (from manganese amino acid complex), 552.6 mg of Co 
(from cobalt carbonate), 1,234,585.2 IU of vitamin A, 152,808.1 IU of vitamin D, 3,815.1 
IU of vitamin E, and 295 mg of Rumensin (Elanco Animal Health, Greenfield, IN). 
4Based on tabular value (NRC, 2001).  







Table 3-2. Energy and protein supply and AA balance of the basal diet supplemented with 
N-acetyl-L-Met (NALM) at 2 different doses 
 Diet1 
Item Control 30NALM  60NALM 
Energy supply2    
   NEL, Mcal/kg 1.65 1.65 1.65 
   ME, Mcal/d 66.2 66.2 66.2 
   ME, Mcal/kg 2.58 2.58 2.58 
Protein supply,2 g/d    
   MP supply 2,940 2,955 2,975 
MP requirements 2,880 2,880 2,880 
MP balance 60 75 95 
Lys and Met balance,3 g/d    
dLys requirement 191 191 191 
dLys supplied by the diet 193 193 193 
Lys balance 2.00 2.00 2.00 
dMet requirement 63.0 63.0 63.0 
dMet supplied by the diet 63.0 63.0 63.0 
dMet from Met derivative 0.00 15.6 31.2 
Total dMet in the diet 63.0 78.6 94.2 




dLys:dMet4 3.06 2.46 2.05 
 
1Control = basal diet without NALM supplementation; 30NALM = control diet with 30 g/d 
of supplemented NALM; and 60NALM = control diet with 60 g/d of supplemented 
NALM. 
2All values were estimated using NRC (2001) based on actual DMI, milk yield, milk 
composition, and BW of the cows throughout the trial. 
3Digestible Lys (dLys) and digestible Met (dMet) supply from the diets were estimated 
using NRC (2001); supply of dMet from Met derivative was estimated with Met 
concentration (78%) and absorption (67%) data provided by the manufacturer. 
Requirements of dLys and dMet were calculated as 6.6 and 2.2% of MP requirements, 
respectively. 












Table 3-3. Intake, milk production, feed efficiency, and milk urea nitrogen of lactating 





Control 30NALM 60NALM NALM L Q 
DMI, kg/d 20.4 20.7 20.3 1.55 0.96 0.83 0.65 
Yield, kg/d        
Milk 30.9 31.3 30.9 1.79 0.84 0.99 0.69 
3.5% FCM3 33.2 33.5 32.6 2.27 0.94 0.85 0.85 
ECM4 32.7 33.0 32.0 2.35 0.91 0.69 0.64 
Milk composition, %        
Fat 3.98 3.96 3.87 0.157 0.77 0.69 0.91 
True protein 2.85 2.87 2.77 0.086 0.75 0.47 0.51 
Lactose 4.74 4.73 4.73 0.136 0.77 0.75 0.98 
Milk component yield, 
kg/d 
       
Fat 1.23 1.23 1.19 0.088 0.89 0.80 0.86 
True protein 0.87 0.90 0.85 0.076 0.98 0.65 0.42 
Lactose 1.47 1.47 1.46 0.103 0.99 0.87 0.77 
Feed efficiency        






1.65 1.63 1.63 0.096 0.81 0.82 0.93 
ECM yield/DMI 1.62 1.60 1.60 0.086 0.83 0.83 0.96 
MUN, mg/100 mL 12.3 11.2 10.7 1.19 0.05 0.02 0.42 
 
1Control = basal diet without NALM supplementation; 30NALM = control diet with 30 g/d 
of supplemented NALM; and 60NALM = control diet with 60 g/d of supplemented 
NALM. 
2NALM = control vs. NALM treatments; L = linear effect of increasing NALM 
supplementation; Q = quadratic effect of increasing NALM supplementation. 
33.5% FCM = [0.4324 × milk yield (kg/d)] + [16.216 × fat yield (kg/d)]. 













Table 3-4. Plasma AA concentrations (µmol/L) of lactating Holstein dairy cows 





Control 30NALM 60NALM NALM L Q 
Arg 42.9 46.9 42.0 2.1 0.55 0.76 0.08 
His 38.9 42.5 37.4 1.66 0.61 0.52 0.03 
Ile 74.8 74.8 67.2 3.16 0.33 0.09 0.32 
Leu 136 128 113 5.2 0.02 < 0.01 0.57 
Lys 58.2 59.2 54.7 2.51 0.68 0.32 0.37 
Met 16.0 21.6 22.1 1.07 < 0.01 < 0.01 0.06 
Phe 42.2 40.3 36.4 1.56 0.05 0.01 0.61 
Val 209 202 183 7.8 0.10 0.02 0.49 
EAA3 617 616 556 24.3 0.30 0.08 0.33 
Ala 190 179 170 7.78 0.11 0.07 0.97 
Gly 194 224 211 9.48 0.05 0.23 0.07 
Ser 54.4 65.6 57.6 2.52 0.02 0.37 < 0.01 
Tyr 40.5 41.4 37.3 1.51 0.54 0.14 0.18 
NEAA4 479 510 475 20.6 0.59 0.89 0.19 
 
1Control = basal diet without NALM supplementation; 30NALM = control diet with 30 g/d 





2NALM = control vs. NALM treatments; L = linear effect of increasing NALM 
supplementation; Q = quadratic effect of increasing NALM supplementation. 
3Essential AA analyzed.  



































Table 3-5. Determination of bioavailability and kinetic parameters in lactating Holstein dairy 





Control 30NALM 60NALM NALM L Q 
Basal plasma Met 
concentration (BPC), µM 
25.4 39.7 39.5 2.55 < 0.01 < 0.01 0.04 
Peak time after abomasal 
infusion, h 
2:35 2:45 3:15 0.50 0.52 0.38 0.79 
Peak Met height after 
abomasal infusion, µM  
45.4 65.4 84.1 13.0 0.16 0.12 0.97 
Area under the curve (AUC), 
µM × h/L 
295 463 479 20.5 < 0.01 < 0.01 < 0.01 
AUC per Met unit,3 (µM × 
h/L)/Met (g) 
4.68 5.89 5.07 0.24 0.01 0.14 < 0.01 
Met bioavailability of 
NALM,4 % 
100 139 115 0.07 < 0.01 0.09 < 0.01 
Plasma NALM concentration ND5 ND ND - - - - 
 
1Control = basal diet without NALM supplementation; 30NALM = control diet with 30 g/d 





2NALM = control vs. NALM treatments; L = linear effect of increasing NALM 
supplementation; Q = quadratic effect of increasing NALM supplementation. 
3AUC per Met unit = area under the curve ÷ total dMet concentration in the diet (g).  
4Bioavailability = (AUC per Met unit ÷ AUC per Met unitControl) × 100. 




















Table 3-6. Residue potential in lactating Holstein dairy cows supplemented with N-acetyl-L-
Met (NALM) at 2 different doses 
Item 
Diet1  Contrast2 
Control 30NALM 60NALM SEM NALM L Q 
Milk NALM, (µM) ND2 ND ND - - - - 
Milk Met, (µM) 8.17 6.42 10.3 2.67 0.59 0.58 0.41 
Tissue NALM, (µM)        
Liver ND ND ND - - - - 
Muscle ND ND ND - - - - 
Tissue Met, (µg/g)        
Liver 15.6 25.4 22.9 1.16 < 0.01 0.01 0.01 
Muscle 9.18 13.1 13.7 1.27 0.08 0.10 0.36 
 
1Control = basal diet without NALM supplementation; 30NALM = control diet with 30 g/d 
of supplemented NALM; and 60NALM = control diet with 60 g/d of supplemented 
NALM. 








Figure 3-1. Plasma Met concentration (µM) versus time plot for lactating Holstein dairy cows 






















































Amino acid and protein nutrition in lactating dairy cows remain a topic of great 
interest to researchers and the dairy industry. Substantial progress has been made over the 
years in the development of rumen-protected forms of lysine and methionine. Lysine and 
methionine have traditionally been identified as the most limiting essential amino acids 
for lactating dairy cows. As more complex feeding models are developed, the 
incorporation of a multiple-limiting amino acid model that includes branched-chain 
amino acids (i.e., isoleucine, leucine, and valine) and additional essential amino acids, 
(i.e, histidine, lysine, and methionine) if not all 10 essential amino acids could help to 
reduce protein overfeeding, improve post-ruminal amino acid supply, decrease nitrogen 
excretion, and improve lactational performance.  
This dissertation investigated the use of acetylated methionine and lysine derivatives 
as a source of rumen-protected amino acids for lactating dairy cows. Acetylated amino 
acid derivatives are a free amino acid molecule with a chemical blocking group (acetyl 
group) added to the either the ε-amino or α-amino group. Chapter 1 focused on 
investigating production responses and ruminal fermentation characteristics of lactating 
dairy cows when supplemented with N-acetyl-L-Methionine as a source of rumen-
protected methionine in metabolizable protein-deficient and -adequate diets. Improving 
the total balance of amino acids in metabolizable protein has been one strategy used to 
optimize lactational performance, while reducing the amount of dietary crude protein fed 




methionine to improve lactational performance in dairy cows, but have obtained 
inconsistent findings due to various feeding, physiological and complex inter-organ 
metabolism of methionine by the rumen, liver, and mammary gland. Our objective was to 
investigate lactational performance and nutrient utilization of early to mid-lactating dairy 
cows supplemented without or with a developmental N-acetyl-L-methionine in 
metabolizable protein-deficient or -adequate diets. Overall, the results demonstrated that 
N-acetyl-L-methionine exerted minor influence on ruminal metabolism, but increased 
milk fat concentration, which was an unexpected finding, possibly due to accelerated 
fatty acid delivery from the liver to the mammary gland, resulting in sizable increases in 
milk fat yield and feed efficiency.  
In chapter 2, the objective was to investigate lactational performance and nutrient 
utilization by mid to late lactating dairy cows supplemented with three different forms of 
rumen-protected lysine (2 developmental lysine derivatives and 1 commercially available 
lysine supplement). Results of the study demonstrate that feeding the Nα, ε-acetyl-L-
lysine supplemented diet in mid to late lactation dairy cows decreased dry matter intake 
and maintained milk yield, leading to greater feed efficiency compared to the control diet. 
These findings suggest that the developmental N-acetyl-L-lysine products (Nα, ε-acetyl-
L-Lysine and Nε-acetyl-L-Lysine) may be biologically active in lactating dairy cows, 
with Nα, ε-acetyl-L-lysine showing the most benefit to improve feed efficiency and 
increase milk yield. However, further research is needed to discover the role of lysine 




lactating dairy cows as this was the first attempt to evaluate the use of lysine derivatives 
in lactating dairy cows.  
In chapter 3, the objective of the study was to evaluate the bioavailability and 
lactational performance of lactating dairy cows supplemented with N-acetyl-L-
methionine at 2 different doses (30 and 60 g/d). To date, there had been no research 
reported on the effects of supplementing N-acetyl-L-methionine on bioavailability and 
safety to lactating dairy cows. Overall, production parameters were not influenced by N-
acetyl-L-methionine supplementation, which was not surprising given the short study 
periods. Plasma methionine increased with N-acetyl-L-methionine dosing, while 
individual branched chain amino acid concentrations decreased, which was an 
unexpected finding. Bioavailability by plasma appearance of methionine for N-acetyl-L-
methionine treatments was higher for the 30 g/d N-acetyl-L-methionine dose compared 
with the 60 g/d N-acetyl-L-methionine and control dose, suggesting that the optimal 
supplementation rate for N-acetyl-L-methionine is 30 g/cow/d. N-acetyl-L-methionine 
was not detected in plasma, milk, liver or muscle samples. This again was the first 
attempt to measure the bioavailability of the methionine derivative in lactating dairy 
cattle and the findings suggest that N-acetyl-L-methionine is deacetylated before reaching 
central circulation, increases plasma methionine concentrations, and supplies lactating 
dairy cows with a safe bioavailable source of rumen-protected methionine. Although 
there were differences observed between studies in lactational performance (chapter 1-3), 




use in lactating dairy cows and both methionine and lysine derivatives should be 
considered as a source of rumen-protected amino acids for lactating dairy cows.  
The daily profit per lactating dairy cow being fed with rumen protected methionine 
has been estimated to be around 30 cents (Cho et al., 2007; Chen et al., 2011). Dairy 
nutritionists commonly report a return on investment of 2.5:1 or higher when rations are 
balanced for rumen protected lysine and methionine in metabolizable protein (Schwab, 
2012). Additionally, increases in income over feed cost approaching 40 to 50 cents per 
cow per day from precision balancing for rumen degradable protein and rumen 
undegradable protein, while balancing for lysine and methionine have been described by 
dairy nutritionists (Schwab, 2012). The concept of the multiple-limiting amino acid 
model may be profitable based on the values above through precision feeding, however 
the environmental impacts of reducing nitrogen excretion by lysine and methionine 
derivative supplementation should not be overlooked. 
Consumers of dairy products are aware of the environmental impacts of feeding and 
raising livestock animals. Animal agriculture has been identified as a major source of 
nitrogen pollution to water resources. Animal wastes can contribute to nitrogen pollution 
of the environment as ammonia volatilized to the air, nitrate leached into ground water, 
and nitrogen that runs off to surface water. Improvement of nitrogen utilization efficiency 
by lactating dairy cows fed with amino acid derivatives could decrease nitrogen losses 





Although considerable advancements have been made in amino acid nutrition, future 
works need to focus on the development of products and technologies that promote 
animal health (i.e., improved immunity) through balanced feeding allowing for lower 
protein diets and increased microbial protein synthesis. Further works could include the 
use of acetylated amino acid derivative mixtures supplemented to lactating dairy cows. 
Additionally, future works should focus on the “real-life” estimates of potential 
reductions in nitrogen excretion by supplementing amino acid derivatives through 
improving the amino acid profile reaching the small intestine. Future research needs to 
focus on longer term feeding periods during various stages of lactation (i.e., early, mid or 
late). The study durations should be extended to measure responses with larger sample 
sizes and explore the biological and commercial significance of the dietary treatments. 
This could also allow researchers to pinpoint when acetylated amino acid derivatives 
exert the greatest effects to dairy cows during lactation. It will also aid dairy farmers on 
deciding the optimal time to feed acetylated amino acid derivatives to lactating dairy 
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